Jump to content

Use of assisted reproductive technology by LGBT people: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Reverted edits by Willmorrish (talk) (AV)
Line 7: Line 7:
Lack of access to assisted reproductive technologies has been seen as a form of [[healthcare inequality]] experienced by LGBT people.<ref>{{cite journal | vauthors = Tam MW | title = Queering reproductive access: reproductive justice in assisted reproductive technologies | journal = Reproductive Health | volume = 18 | issue = 1 | pages = 164 | date = August 2021 | pmid = 34340704 | pmc = 8327458 | doi = 10.1186/s12978-021-01214-8 | doi-access = free }}</ref>
Lack of access to assisted reproductive technologies has been seen as a form of [[healthcare inequality]] experienced by LGBT people.<ref>{{cite journal | vauthors = Tam MW | title = Queering reproductive access: reproductive justice in assisted reproductive technologies | journal = Reproductive Health | volume = 18 | issue = 1 | pages = 164 | date = August 2021 | pmid = 34340704 | pmc = 8327458 | doi = 10.1186/s12978-021-01214-8 | doi-access = free }}</ref>


== Gay men ==
== ==
{{main|Male egg|Artificial womb}}
Some gay couples decide to have a surrogate [[pregnancy]]. A surrogate is a woman carrying an egg fertilized by sperm of one of the men. Some women become surrogates for money, others for humanitarian reasons or both.<ref>{{cite web|url=http://www.ihr.com/infertility/surrogacy/gay-parent-through-surrogacy.html|title=For Gay Men: Becoming a Parent through Surrogacy|access-date=26 July 2015 | work = Internet Health Resources }}</ref> This allows one of the men to be the biological father while the other will be an adopted father.


=== Donating sperm ===
Gay men who have become fathers using surrogacy have reported similar experiences to those as other couples who have used surrogacy, including their relationships both their child and their surrogate have.<ref>{{cite journal | vauthors = Blake L, Carone N, Slutsky J, Raffanello E, Ehrhardt AA, Golombok S | title = Gay father surrogacy families: relationships with surrogates and egg donors and parental disclosure of children's origins | journal = Fertility and Sterility | volume = 106 | issue = 6 | pages = 1503–1509 | date = November 2016 | pmid = 27565261 | pmc = 5090043 | doi = 10.1016/j.fertnstert.2016.08.013 }}</ref>


Trans women may have lower sperm quality before HRT, which may pose an issue for creating viable sperm samples to freeze.<ref>{{cite journal | vauthors = Li K, Rodriguez D, Gabrielsen JS, Centola GM, Tanrikut C | title = Sperm cryopreservation of transgender individuals: trends and findings in the past decade | journal = Andrology | volume = 6 | issue = 6 | pages = 860–864 | date = November 2018 | pmid = 30094956 | pmc = 6301129 | doi = 10.1111/andr.12527 }}</ref>
There is theoretical work being done on creating a [[zygote]] from two men which would enable both men to be biological fathers, but it is yet to be practically implemented.<ref name = "Ringler_2015">{{cite web | vauthors = Ringler G | date = 18 March 2015 |url=https://time.com/3748019/same-sex-couples-biological-children/|title=Get Ready for Embryos From Two Men or Two Women|access-date=4 July 2021}}</ref>


Estrogens suppress testosterone levels and at high doses can markedly disrupt sex drive and function and fertility on their own.<ref name="JonesReiter2016">{{cite journal | vauthors = Jones CA, Reiter L, Greenblatt E |title=Fertility preservation in transgender patients |journal=International Journal of Transgenderism |volume=17 |issue=2 |year=2016 |pages=76–82 |issn=1553-2739 |doi=10.1080/15532739.2016.1153992 |s2cid=58849546 |quote=Traditionally, patients have been advised to cryopreserve sperm prior to starting cross-sex hormone therapy as there is a potential for a decline in sperm motility with high-dose estrogen therapy over time (Lubbert et al., 1992). However, this decline in fertility due to estrogen therapy is controversial due to limited studies.}}</ref><ref name="PayneHardy2007">{{cite book | vauthors = Payne AH, Hardy MP |title=The Leydig Cell in Health and Disease |url=https://books.google.com/books?id=x4ttqKIAOg0C&pg=PA422 |date=28 October 2007 |publisher=Springer Science & Business Media |isbn=978-1-59745-453-7 |pages=422–431 |quote=Estrogens are highly efficient inhibitors of the hypothalamic-hypophyseal-testicular axis (212–214). Aside from their negative feedback action at the level of the hypothalamus and pituitary, direct inhibitory effects on the testis are likely (215,216). [...] The histology of the testes [with estrogen treatment] showed disorganization of the seminiferous tubules, vacuolization and absence of lumen, and compartmentalization of spermatogenesis.}}</ref><ref name="Salam2003">{{cite book | vauthors = Salam MA |title=Principles & Practice of Urology: A Comprehensive Text |url=https://books.google.com/books?id=y50kTcCCfEcC&pg=PA684 |year=2003 |publisher=Universal-Publishers |isbn=978-1-58112-412-5 |pages=684– |quote=Estrogens act primarily through negative feedback at the hypothalamic-pituitary level to reduce LH secretion and testicular androgen synthesis. [...] Interestingly, if the treatment with estrogens is discontinued after 3 yr. of uninterrupted exposure, serum testosterone may remain at castration levels for up to another 3 yr. This prolonged suppression is thought to result from a direct effect of estrogens on the Leydig cells.}}</ref><ref name="pmid7500443">{{cite journal | vauthors = Cox RL, Crawford ED | title = Estrogens in the treatment of prostate cancer | journal = The Journal of Urology | volume = 154 | issue = 6 | pages = 1991–8 | date = December 1995 | pmid = 7500443 | doi = 10.1016/S0022-5347(01)66670-9 }}</ref> Moreover, disruption of gonadal function and fertility by estrogens may be permanent after extended exposure.<ref name="Salam2003" /><ref name="pmid7500443" /><ref>{{cite journal | vauthors = Adeleye AJ, Reid G, Kao CN, Mok-Lin E, Smith JF | title = Semen Parameters Among Transgender Women With a History of Hormonal Treatment | language = English | journal = Urology | volume = 124 | pages = 136–141 | date = February 2019 | pmid = 30312673 | doi = 10.1016/j.urology.2018.10.005 | s2cid = 52973277 }}</ref>
Barrie and Tony Drewitt-Barlow from the United Kingdom became the first gay men in the country to father twins born through surrogacy in 1999.<ref name="Woodward">{{cite news | vauthors = Woodward W |title=Gay couple celebrate birth of twins Aspen and Saffron |url= https://www.theguardian.com/uk/1999/dec/13/willwoodward1 |work=The Guardian |date=13 December 1999}}</ref><ref name="Wakefield">{{cite web | vauthors = Wakefield L |title=Britain's 'first gay dads' expecting triplets with daughter's ex-boyfriend |url=https://www.pinknews.co.uk/2021/12/13/uk-birth-certificates-gay-dads-barrie-tony-drewitt-barlow/ |website=PinkNews |date=13 December 2021}}</ref>

Nonsteroidal antiandrogens like [[bicalutamide]] may be an option for transgender women who wish to preserve [[sex drive]], [[sexual function]], and/or [[fertility]], relative to antiandrogens that suppress testosterone levels and can greatly disrupt these functions such as cyproterone acetate and GnRH modulators.<ref name="pmid29352423">{{cite journal | vauthors = Gao Y, Maurer T, Mirmirani P | title = Understanding and Addressing Hair Disorders in Transgender Individuals | journal = American Journal of Clinical Dermatology | volume = 19 | issue = 4 | pages = 517–527 | date = August 2018 | pmid = 29352423 | doi = 10.1007/s40257-018-0343-z | quote = Non-steroidal antiandrogens include flutamide, nilutamide, and bicalutamide, which do not lower androgen levels and may be favorable for individuals who want to preserve sex drive and fertility [9]. | s2cid = 6467968 }}</ref><ref name="IversenMelezinek2001">{{cite journal | vauthors = Iversen P, Melezinek I, Schmidt A | title = Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function | journal = BJU International | volume = 87 | issue = 1 | pages = 47–56 | date = January 2001 | pmid = 11121992 | doi = 10.1046/j.1464-410x.2001.00988.x | s2cid = 28215804 | doi-access = free }}</ref><ref name="MorganteGradini2001">{{cite journal | vauthors = Morgante E, Gradini R, Realacci M, Sale P, D'Eramo G, Perrone GA, Cardillo MR, Petrangeli E, Russo M, Di Silverio F | display-authors = 6 | title = Effects of long-term treatment with the anti-androgen bicalutamide on human testis: an ultrastructural and morphometric study | journal = Histopathology | volume = 38 | issue = 3 | pages = 195–201 | date = March 2001 | pmid = 11260298 | doi = 10.1046/j.1365-2559.2001.01077.x | hdl = 11573/387981 | s2cid = 36892099 }}</ref> However, estrogens suppress testosterone levels and at high doses can markedly disrupt sex drive and function and fertility on their own.<ref name="JonesReiter20162">{{cite journal | vauthors = Jones CA, Reiter L, Greenblatt E |year=2016 |title=Fertility preservation in transgender patients |journal=International Journal of Transgenderism |volume=17 |issue=2 |pages=76–82 |doi=10.1080/15532739.2016.1153992 |issn=1553-2739 |quote=Traditionally, patients have been advised to cryopreserve sperm prior to starting cross-sex hormone therapy as there is a potential for a decline in sperm motility with high-dose estrogen therapy over time (Lubbert et al., 1992). However, this decline in fertility due to estrogen therapy is controversial due to limited studies. |s2cid=58849546}}</ref><ref name="PayneHardy20072">{{cite book | vauthors = Payne AH, Hardy MP |url=https://books.google.com/books?id=x4ttqKIAOg0C&pg=PA422 |title=The Leydig Cell in Health and Disease |date=28 October 2007 |publisher=Springer Science & Business Media |isbn=978-1-59745-453-7 |pages=422–431 |quote=Estrogens are highly efficient inhibitors of the hypothalamic-hypophyseal-testicular axis (212–214). Aside from their negative feedback action at the level of the hypothalamus and pituitary, direct inhibitory effects on the testis are likely (215,216). [...] The histology of the testes [with estrogen treatment] showed disorganization of the seminiferous tubules, vacuolization and absence of lumen, and compartmentalization of spermatogenesis. |name-list-style=vanc}}</ref><ref name="Salam20032">{{cite book | vauthors = Salam MA |url=https://books.google.com/books?id=y50kTcCCfEcC&pg=PA684 |title=Principles & Practice of Urology: A Comprehensive Text |publisher=Universal-Publishers |year=2003 |isbn=978-1-58112-412-5 |pages=684– |quote=Estrogens act primarily through negative feedback at the hypothalamic-pituitary level to reduce LH secretion and testicular androgen synthesis. [...] Interestingly, if the treatment with estrogens is discontinued after 3 yr. of uninterrupted exposure, serum testosterone may remain at castration levels for up to another 3 yr. This prolonged suppression is thought to result from a direct effect of estrogens on the Leydig cells. |name-list-style=vanc}}</ref><ref name="pmid75004432">{{cite journal | vauthors = Cox RL, Crawford ED | title = Estrogens in the treatment of prostate cancer | journal = The Journal of Urology | volume = 154 | issue = 6 | pages = 1991–1998 | date = December 1995 | pmid = 7500443 | doi = 10.1016/S0022-5347(01)66670-9 }}</ref> Moreover, disruption of gonadal function and fertility by estrogens may be permanent after extended exposure.<ref name="Salam20032" /><ref name="pmid75004432" />

=== Picking sperm ===
Prospective parents must carefully consider where they get their donor sperm from. Indvidual state's laws vary, but many U.S states have adopted a form of the [[Uniform Parentage Act]] (UPA).<ref name=":0">{{Cite journal |last1=Luetkemeyer |first1=Lisa |last2=West |first2=Kimela |date=2015 |title=Paternity Law: Sperm Donors, Surrogate Mothers and Child Custody |journal=Missouri Medicine |volume=112 |issue=3 |pages=162–165 |issn=0026-6620 |pmc=6170122 |pmid=26168582}}</ref> Most, but not all states transfer parental rights from anonymous [[Sperm donation|sperm donors]] to the intended parents as long as the recipient is a married woman, and a physician is involved.<ref name=":0" /> Noncompliance with these laws can result in the failure to terminate sperm donor parental rights. There have been court cases where known sperm donors that privately donated directly were requested to pay [[child support]].<ref name=":0" /><ref>{{Cite web |last=Narayan |first=Chandrika |date=2014-01-23 |title=Kansas court says sperm donor must pay child support |url=https://www.cnn.com/2014/01/23/justice/kansas-sperm-donation/index.html |access-date=2023-11-16 |website=CNN |language=en}}</ref><ref>{{Cite web |date=2021-06-16 |title=Court voids ruling that sperm donor must pay child support |url=https://apnews.com/article/child-support-health-government-and-politics-342e0699fa1055fdceb15854ee75e58c |access-date=2023-11-16 |website=AP News |language=en}}</ref><ref>{{Cite web |date=2018-07-16 |title=Do Sperm Donors Pay Child Support? |url=https://www.boydlawlosangeles.com/do-sperm-donors-pay-child-support/ |access-date=2023-11-16 |website=Boyd Law |language=en-US}}</ref> For example, of these laws, see [https://www.nclrights.org/wp-content/uploads/2015/11/Cal-statutory-forms-assisted-reproduction.pdf California assisted reproductive laws]. In Australia, there has been legal precedent that sperm donor involvement with the ensuing child's life does grant them parental rights (Masson v Parsons).<ref>{{Cite web |last=Seery |first=Cassandra |date=2019-06-19 |title=Can a sperm donor be a legal parent? In landmark decision, the High Court says yes |url=http://theconversation.com/can-a-sperm-donor-be-a-legal-parent-in-landmark-decision-the-high-court-says-yes-115553 |access-date=2023-11-16 |website=The Conversation |language=en-US}}</ref>

Alternative to direct private donation it is possible to purchase sperm from a [[sperm bank]] for personal use in fertility treatment. Sperm banks can vary widely, not only in terms of price, but of practice (i.e who is allowed to donate sperm, how many times, etc) and can offer a variety of services. Major U.S sperm banks include Fairfax Cryobank, [[California Cryobank|California Cyrobank]], [[Cryos International]], Seattle Sperm bank, and Xytex, and many others.

=== Procedures ===
Timing of these procedures are critical for successful fertilization,<ref name=":5">{{Cite journal |last1=Potapragada |first1=Nivedita R. |last2=Babayev |first2=Elnur |last3=Strom |first3=Danielle |last4=Beestrum |first4=Molly |last5=Schauer |first5=Jacob M. |last6=Jungheim |first6=Emily S. |date=2023-06-07 |title=Intrauterine Insemination After Human Chorionic Gonadotropin Trigger or Luteinizing Hormone Surge |url=http://dx.doi.org/10.1097/aog.0000000000005222 |journal=Obstetrics & Gynecology |volume=142 |issue=1 |pages=61–70 |doi=10.1097/aog.0000000000005222 |s2cid=259118454 |issn=0029-7844}}</ref> as the fertile window is the five days before ovulation, plus the day of and after ovulation.<ref name=":20">{{Cite web |date=2022-03-10 |title=Calculating Your Monthly Fertility Window |url=https://www.hopkinsmedicine.org/health/wellness-and-prevention/calculating-your-monthly-fertility-window |access-date=2023-12-04 |website=www.hopkinsmedicine.org |language=en}}</ref> To increase the chance of success, the menstrual cycle is closely observed, often using ovulation kits, ultrasounds or blood tests, such as [[basal body temperature]] tests over, noting the color and texture of the vaginal mucus, and the softness of the nose of the cervix.<ref name=":20" /> To improve the success rate of artificial insemination, drugs to create a [[Controlled ovarian hyperstimulation|stimulated cycle]] may be used called [[Controlled ovarian hyperstimulation|ovarian stimulation]] (OS).

==== [[Intrauterine insemination|Intrauterine insemination (IUI)]] ====
Before ovulation there is a surge of luteinizing hormone (LH) which can be used to time an IUI procedure. Data suggest that IUI should be performed 1 day after the detection of the LH surge.<ref name=":5" /> Most clinics in the U.S perform IUI in the morning after a positive ovulation predictor kit test (which detects LH in urine).<ref name=":5" /> An alternative to LH monitoring is ultrasound monitoring of ovarian follicle size followed by a trigger shot with exogenous human chorionic gonadotropin (hCG) which mimics the body’s LH surge and triggers final follicular maturation and rupture (36–48 hours later). The trigger shot is typically administered when the dominant follicle reaches 18–20 mm.<ref name=":5" /> The recommended timing of IUI after hCG administration is 24–40 hours.<ref name=":5" /> IUI cycles stimulated with classical doses of FSH have a high rate of have a multiple pregnancy with rates ranging from 10 to 40%.<ref name=":6">{{Cite journal |last=The ESHRE Capri Workshop Group |date=2009-01-16 |title=Intrauterine insemination |url=https://academic.oup.com/humupd/article-lookup/doi/10.1093/humupd/dmp003 |journal=Human Reproduction Update |language=en |volume=15 |issue=3 |pages=265–277 |doi=10.1093/humupd/dmp003 |pmid=19240042 |issn=1355-4786}}</ref> A meta-analysis showed no difference between pregnancy outcomes between at-home LH monitoring and timed IUI.<ref name=":5" />

IUI can be done without the use of medication. IUI is not recommended in cases where the gestating individuals have cervical atresia, cervicitis, endometritis or bilateral tubal obstruction or when the sperm donor has amenorrhea or severe oligospermia.<ref name=":6" /> Prior to IUI, the sperm is "washed" which is necessary to remove seminal plasma to avoid prostaglandin-induced uterine contractions.<ref name=":6" /> Insemination with unprocessed semen is also associated with pelvic infection.<ref name=":6" />
[[File:IUI.png|thumb|Diagram of the IUI procedure]]
Intrauterine insemination (IUI) involves the opening of the vagina using a speculum, then injecting washed sperm directly into the uterus with a [[catheter]].<ref>{{Cite web |title=Intrauterine insemination (IUI) - Mayo Clinic |url=https://www.mayoclinic.org/tests-procedures/intrauterine-insemination/about/pac-20384722 |access-date=2023-11-26 |website=www.mayoclinic.org}}</ref> Insemination in this way means that the sperm do not have to swim through the cervix which is coated with a mucus layer. This layer of mucus can slow down the passage of sperm and can result in many sperm perishing before they can enter the uterus.<ref>{{Cite web |title=IUI (Intrauterine Insemination): What It Is & What To Expect |url=https://my.clevelandclinic.org/health/treatments/22456-iui-intrauterine-insemination |access-date=2023-11-26 |website=Cleveland Clinic |language=en}}</ref> Donor sperm is sometimes tested for mucus penetration capabilities if it is to be used for ICI inseminations, for if the sperm's chances of passing through the cervix is low, IUI would provide a more efficient delivery of the sperm than ICI {{citation needed|date=December 2023}}. IUI fertilization takes place naturally in the external part of the fallopian tubes in the same way that occurs following intercourse.

The benefit of double IUI has not been found in patients with undocumented infertility using donor sperm, such as lesbian and single women.<ref>{{Cite journal |last1=Monseur |first1=Brent C. |last2=Franasiak |first2=Jason M. |last3=Sun |first3=Li |last4=Scott |first4=Richard T. |last5=Kaser |first5=Daniel J. |date=2019-10-01 |title=Double intrauterine insemination (IUI) of no benefit over single IUI among lesbian and single women seeking to conceive |url=https://doi.org/10.1007/s10815-019-01561-3 |journal=Journal of Assisted Reproduction and Genetics |language=en |volume=36 |issue=10 |pages=2095–2101 |doi=10.1007/s10815-019-01561-3 |issn=1573-7330 |pmc=6823402 |pmid=31410635}}</ref> Typically pregnancy success rates per IUI cycle is approximately 12.4%.<ref name=":7">{{Cite journal |last1=Johal |first1=Jasmyn K. |last2=Gardner |first2=Rebecca M. |last3=Vaughn |first3=Sara J. |last4=Jaswa |first4=Eleni G. |last5=Hedlin |first5=Haley |last6=Aghajanova |first6=Lusine |date=2021-04-28 |title=Pregnancy success rates for lesbian women undergoing intrauterine insemination |journal=F&S Reports |volume=2 |issue=3 |pages=275–281 |doi=10.1016/j.xfre.2021.04.007 |issn=2666-3341 |pmc=8441558 |pmid=34553151}}</ref> According to a study from 2021, lesbian women undergoing IUI had a clinical pregnancy rate of 13.2% per cycle and 42.2% success rate given the average number of cycles at 3.6.<ref name=":7" /> IUI has been reported to be more effective than ICI<ref name=":11">{{Cite journal |last1=Chen |first1=Xiao-Jun |last2=Wu |first2=Li-Ping |last3=Lan |first3=Hai-Lian |last4=Zhang |first4=Li |last5=Zhu |first5=Yi-Min |date=2012 |title=Clinical Variables Affecting The Pregnancy Rate of Intracervical Insemination Using Cryopreserved Donor Spermatozoa: A Retrospective Study in China |journal=International Journal of Fertility & Sterility |volume=6 |issue=3 |pages=179–184 |issn=2008-076X |pmc=3850307 |pmid=24520436}}</ref><ref name=":10">{{Cite journal |last1=Kop |first1=P A L |last2=van Wely |first2=M |last3=Nap |first3=A |last4=Soufan |first4=A T |last5=de Melker |first5=A A |last6=Mol |first6=B W J |last7=Bernardus |first7=R E |last8=De Brucker |first8=M |last9=Janssens |first9=P M W |last10=Pieters |first10=J J P M |last11=Repping |first11=S |last12=van der Veen |first12=F |last13=Mochtar |first13=M H |date=2022-04-23 |title=Intracervical insemination versus intrauterine insemination with cryopreserved donor sperm in the natural cycle: a randomized controlled trial |url=http://dx.doi.org/10.1093/humrep/deac071 |journal=Human Reproduction |volume=37 |issue=6 |pages=1175–1182 |doi=10.1093/humrep/deac071 |pmid=35459949 |pmc=9789751 |issn=0268-1161}}</ref> but this has been contested with some citing no strong evidence to confirm a significant difference between the birth rates of the two procedures.<ref>{{Cite journal |last1=Kop |first1=Petronella AL |last2=Mochtar |first2=Monique H |last3=O'Brien |first3=Paul A |last4=Van der Veen |first4=Fulco |last5=van Wely |first5=Madelon |date=2018-01-25 |title=Intrauterine insemination versus intracervical insemination in donor sperm treatment |url=http://dx.doi.org/10.1002/14651858.cd000317.pub4 |journal=Cochrane Database of Systematic Reviews |volume=2018 |issue=2 |pages=CD000317 |doi=10.1002/14651858.cd000317.pub4 |pmid=29368795 |pmc=6491301 |issn=1465-1858}}</ref> It is speculated that IUI is more effective since IUI brings the sperm closer to the oocyte than ICI which might compensate for decreased sperm motility after freezing and thawing.<ref name=":10" /> IUI includes risk of [[endometritis]], cramping, bleeding, and [[anaphylaxis]] (rarely).<ref name=":11" /> A systematic review and meta-analysis was not able to demonstrate that bed rest after intrauterine insemination effectively increases in pregnancy rate.<ref>{{Cite journal |last1=Cordary |first1=D. |last2=Braconier |first2=A. |last3=Guillet-May |first3=F. |last4=Morel |first4=O. |last5=Agopiantz |first5=M. |last6=Callec |first6=R. |date=2017-12-01 |title=Immobilization versus immediate mobilization after intrauterine insemination: A systematic review and meta-analysis |url=https://www.sciencedirect.com/science/article/pii/S2468784717301873 |journal=Journal of Gynecology Obstetrics and Human Reproduction |volume=46 |issue=10 |pages=747–751 |doi=10.1016/j.jogoh.2017.09.005 |pmid=28964965 |issn=2468-7847}}</ref>

==== [[Intracervical insemination|Intracervical insemination (ICI)]] ====
Very similar to IUI, Intracervical insemination (ICI) is the method of artificial insemination which most closely mimics the natural ejaculation of semen by the penis into the vagina during sexual intercourse. ICI is the simplest method of artificial insemination and may also be performed privately in the home instead of at a private practice. ICI is the process of introducing semen into the vagina at the entrance to the [[cervix]],<ref>{{Cite web |date=2022-10-08 |title=Intracervical insemination (ICI) - |url=http://human-fertility.com/intracervical-insemination-ici/ |access-date=2023-11-28 |language=en-US}}</ref> usually by means of a needleless syringe. Sperm used in ICI inseminations does not have to be '[[Sperm washing|washed]]' to remove seminal fluid so raw semen from a private donor may be used. Semen supplied by a sperm bank prepared for ICI or IUI use is also suitable for ICI. A retrospective cohort study showed that total motility and total motile count (TMC) after thawing were associated with ongoing pregnancy rate; with best ICI results at total motility of ≥20% and a total motile count (TMC) of ≥8 × 106 after thawing.<ref name=":9">{{Cite journal |last1=Kop |first1=Petronella |last2=van Wely |first2=Madelon |last3=de Melker |first3=Annemieke |last4=van der Veen |first4=Fulco |last5=Mochtar |first5=Monique |date=2022-02-04 |title=Donor sperm treatment: the role of semen parameters in intracervical insemination, a retrospective cohort study |url=https://www.tandfonline.com/doi/full/10.1080/14647273.2022.2032407 |journal=Human Fertility |volume=26 |issue=5 |language=en |pages=964–970 |doi=10.1080/14647273.2022.2032407 |pmid=35114884 |s2cid=246529633 |issn=1464-7273}}</ref>
During ICI, air is expelled from a needleless syringe which is then filled with semen. A specially-designed syringe, wider and with a more rounded end, may be used for this purpose. Any further enclosed air is removed by gently pressing the plunger forward. The recipient lies on their back and the syringe is inserted into the vagina so that the tip is as close to the entrance to the cervix as possible. A vaginal speculum may be used for this purpose and a catheter may be attached to the tip of the syringe to ensure delivery of the semen as close to the entrance to the cervix as possible. The plunger is then slowly pushed forward and the semen in the syringe is gently emptied deep into the vagina. It is important that the syringe is emptied slowly for safety and for the best results, bearing in mind that the purpose of the procedure is the replicate as closely as possible a natural deposit of the semen in the vagina{{citation needed|date=December 2023}}. The syringe (and catheter if used) may be left in place for several minutes before removal. Following insemination, fertile sperm will swim through the cervix into the uterus and from there to the fallopian tubes in a natural way as if the sperm had been deposited in the vagina through intercourse. A [[conception cap]] instead of a syringe can be used as well.[[File:InVitroFertilization.jpg|thumb|Intracytoplasmic sperm injection]]
[[File:IVF medications.jpg|thumb|IVF drugs]]

== In vitro fertilization ==

=== Standard IVF ===
Standard IVF is the process by which the egg is removed from the ovaries and fertilized outside of the body, and then the pre-embryo is implanted into a uterus<ref name=":18">{{Cite web |last=MarketingInsights |title=Standard IVF |url=https://theivfcenter.com/standard-ivf/ |access-date=2023-12-04 |website=The IVF Center {{!}} Assisted Reproduction and Endocrinology |language=en-US}}</ref>.  There are many steps to ensure that this process works including ovary stimulation, egg collection, fertilization, and embryo transfer.  To stimulate the ovaries to produce more eggs than usual, the person must take specific hormones prescribed by a doctor<ref name=":18" />.  Then, the eggs are collected using an ultrasound-guided aspiration needle.  Once the eggs are outside the body, they are mixed with sperm in a culture dish in the hopes of fertilization.  The sperm used can come from any sperm donor (either from a sperm bank, or a known donor like a partner).  If a pre-embryo forms, it remains in the incubator for two to five days while it continues to grow and divide.  At this stage, the pre-embryo is often genetically tested to ensure that it will develop into a healthy baby.  If the embryo is deemed healthy, the next step is implantation<ref name=":18" />.  The embryos are transferred to the uterus which involves an ultrasound being used to guide a catheter through the cervix and into the uterine cavity.<ref name=":18" />

=== Reciprocal IVF ===


== Lesbians ==
{{main|Female sperm}}
[[Partner-assisted reproduction]], or co-IVF is a method of [[Family planning|family building]] that is used by couples who both possess [[female reproductive organs]]. The method uses [[In vitro fertilisation|in vitro fertilization]] (IVF), a method that means [[Oocyte|eggs]] are removed from the [[Ovary|ovaries]], fertilized in a laboratory, and then one or more of the resulting [[embryo]]s are placed in the [[uterus]] to hopefully create a [[pregnancy]]. Reciprocal IVF differs from standard IVF in that two women are involved: the eggs are taken from one partner, and the other partner carries the pregnancy.<ref>{{Cite news | vauthors = Gilmour P | date = 6 June 2018 |url=https://www.cosmopolitan.com/uk/love-sex/relationships/a17851346/how-lesbian-couples-have-babies/|title=Shared motherhood: The amazing way lesbian couples are having babies |work=Cosmopolitan|access-date=21 March 2018|language=en-GB}}</ref> In this way, the process is mechanically identical to IVF with [[egg donation]].<ref>{{Cite web|url=https://www.huffingtonpost.com/entry/co-maternity-and-reciprocal-ivf-empowering-lesbian_us_594b0f7be4b062254f3a5b69|title=Co-Maternity And Reciprocal IVF: Empowering lesbian parents with options| vauthors = Klatsky P |date=22 June 2017 |website=Huffington Post|language=en-US|access-date=21 March 2018}}</ref><ref name="marina">{{cite journal | vauthors = Marina S, Marina D, Marina F, Fosas N, Galiana N, Jové I | title = Sharing motherhood: biological lesbian co-mothers, a new IVF indication | journal = Human Reproduction | volume = 25 | issue = 4 | pages = 938–41 | date = April 2010 | pmid = 20145005 | doi = 10.1093/humrep/deq008 | doi-access = free }}</ref> Using this process ensures that each partner is a [[biological mother]] of the child according to advocates,<ref>{{Cite book|title=Ethical dilemmas in assisted reproductive technologies|date=2011|publisher=De Gruyter| vauthors = Schenker JG |isbn=978-3-11-024021-4 |location=Berlin|oclc=763156926}}</ref> but in the strictest sense only one mother is the biological mother from a genetic standpoint and the other is a [[surrogate mother]]. However the practice has a symbolic weight greater than [[LGBT adoption]], and may create a stronger bond between mother and child than adoption.
[[Partner-assisted reproduction]], or co-IVF is a method of [[Family planning|family building]] that is used by couples who both possess [[female reproductive organs]]. The method uses [[In vitro fertilisation|in vitro fertilization]] (IVF), a method that means [[Oocyte|eggs]] are removed from the [[Ovary|ovaries]], fertilized in a laboratory, and then one or more of the resulting [[embryo]]s are placed in the [[uterus]] to hopefully create a [[pregnancy]]. Reciprocal IVF differs from standard IVF in that two women are involved: the eggs are taken from one partner, and the other partner carries the pregnancy.<ref>{{Cite news | vauthors = Gilmour P | date = 6 June 2018 |url=https://www.cosmopolitan.com/uk/love-sex/relationships/a17851346/how-lesbian-couples-have-babies/|title=Shared motherhood: The amazing way lesbian couples are having babies |work=Cosmopolitan|access-date=21 March 2018|language=en-GB}}</ref> In this way, the process is mechanically identical to IVF with [[egg donation]].<ref>{{Cite web|url=https://www.huffingtonpost.com/entry/co-maternity-and-reciprocal-ivf-empowering-lesbian_us_594b0f7be4b062254f3a5b69|title=Co-Maternity And Reciprocal IVF: Empowering lesbian parents with options| vauthors = Klatsky P |date=22 June 2017 |website=Huffington Post|language=en-US|access-date=21 March 2018}}</ref><ref name="marina">{{cite journal | vauthors = Marina S, Marina D, Marina F, Fosas N, Galiana N, Jové I | title = Sharing motherhood: biological lesbian co-mothers, a new IVF indication | journal = Human Reproduction | volume = 25 | issue = 4 | pages = 938–41 | date = April 2010 | pmid = 20145005 | doi = 10.1093/humrep/deq008 | doi-access = free }}</ref> Using this process ensures that each partner is a [[biological mother]] of the child according to advocates,<ref>{{Cite book|title=Ethical dilemmas in assisted reproductive technologies|date=2011|publisher=De Gruyter| vauthors = Schenker JG |isbn=978-3-11-024021-4 |location=Berlin|oclc=763156926}}</ref> but in the strictest sense only one mother is the biological mother from a genetic standpoint and the other is a [[surrogate mother]]. However the practice has a symbolic weight greater than [[LGBT adoption]], and may create a stronger bond between mother and child than adoption.


In a 2019 study, quality of infant–parent relationships was examined among egg donor families in comparison to in vitro fertilization families.<ref name="Imrie_2019">{{cite journal | vauthors = Imrie S, Jadva V, Fishel S, Golombok S | title = Families Created by Egg Donation: Parent-Child Relationship Quality in Infancy | journal = Child Development | volume = 90 | issue = 4 | pages = 1333–1349 | date = July 2019 | pmid = 30015989 | pmc = 6640047 | doi = 10.1111/cdev.13124 }}</ref> Infants were between the ages of 6–18 months. Through use of the Parent Development Interview (PDI) and observational assessment, the study found few differences between family types on the representational level, yet significant differences between family types on the observational level.<ref name="Imrie_2019" /> Egg donation mothers were less sensitive and structuring than IVF mothers, and egg donation infants were less emotionally responsive, and involving than IVF infants.<ref name="Imrie_2019"/>
In a 2019 study, quality of infant–parent relationships was examined among egg donor families in comparison to in vitro fertilization families.<ref name="Imrie_2019">{{cite journal | vauthors = Imrie S, Jadva V, Fishel S, Golombok S | title = Families Created by Egg Donation: Parent-Child Relationship Quality in Infancy | journal = Child Development | volume = 90 | issue = 4 | pages = 1333–1349 | date = July 2019 | pmid = 30015989 | pmc = 6640047 | doi = 10.1111/cdev.13124 }}</ref> Infants were between the ages of 6–18 months. Through use of the Parent Development Interview (PDI) and observational assessment, the study found few differences between family types on the representational level, yet significant differences between family types on the observational level.<ref name="Imrie_2019" /> Egg donation mothers were less sensitive and structuring than IVF mothers, and egg donation infants were less emotionally responsive, and involving than IVF infants.<ref name="Imrie_2019"/>
<ref name=":19">{{Cite web |title=Reciprocal IVF {{!}} UCSF Center for Reproductive Health |url=https://crh.ucsf.edu/fertility-treatment/reciprocal-ivf |access-date=2023-12-04 |website=UCSF |language=en}}</ref> The eggs are then fertilized with donor sperm to create embryos, one of which can then be transferred to the second person’s uterus. In this way, one partner contributes the genetic material and the second partner contributes the maternal environment, allowing both partners to have a profound impact on the development of the fetus and child<ref name=":19" />.  The laws around parenthood when both partners do not contribute genetic material are complicated and vary by state, so it is imperative to do research before beginning the process.<ref name=":19" />


=== Freezing eggs ===
There is theoretical work being done on creating a [[zygote]] from two women which would enable both women to be biological mothers, but it is yet to be practically implemented.<ref name = "Ringler_2015" /> Creating a sperm from an egg and using it to fertilize another egg may offer a solution to this issue,<ref name="Murray_2021" /> as could a process analogous to [[somatic cell nuclear transfer]] involving two eggs being fused together.<ref>{{Cite web | vauthors = Foster H |date=2013-08-16|title=Mommy 1 and Mommy 2: Could science end the age of Mom and Dad?|url=https://sitn.hms.harvard.edu/flash/2013/mommy-1-and-mommy-2-could-science-end-the-age-of-mom-and-dad/|access-date=2021-07-05|website=Science in the News|language=en-US}}</ref>
Many gay transgender men choose to freeze their eggs before transitioning, and choose to have a female surrogate carry their child while when the time comes, using their eggs and their cis male partner's sperm. This allows them to avoid the potentially dysphoria inducing experience of pregnancy, or cessation of HRT for collecting eggs at an older age.<ref>{{Cite web | vauthors = Compton J | date = 5 March 2019 |title=Transgender men, eager to have biological kids, are freezing their eggs|url=https://www.nbcnews.com/feature/nbc-out/transgender-men-eager-have-biological-kids-are-freezing-their-eggs-n975331|access-date=2021-07-05|website=NBC News|language=en}}</ref><ref>{{Cite web|title=The T-Male: IVF and Surrogacy|url=http://www.thetransitionalmale.com/Surrogate.html|access-date=2021-07-05|website=www.thetransitionalmale.com}}</ref>


== Natural pregnancy ==
In 2004 and 2018 scientists were able to create mice with two mothers via egg fusion.<ref name="the-washington-post-2004a" /><ref name="blakely-2018a" /><ref name="li-2018a" /> Modification of [[genomic imprinting]] was necessary to create healthy bimaternal mice, while live bipaternal mice were created but were unhealthy likely due to genomic imprinting.<ref name="li-2018a" />
=== Surrogacy ===
{{main|Male egg|Artificial womb}}
Some gay or transsexual couples decide to have a surrogate [[pregnancy]]. A surrogate is a woman carrying an egg fertilized by sperm of one of the men. Some women become surrogates for money, others for humanitarian reasons or both.<ref>{{cite web|url=http://www.ihr.com/infertility/surrogacy/gay-parent-through-surrogacy.html|title=For Gay Men: Becoming a Parent through Surrogacy|access-date=26 July 2015 | work = Internet Health Resources }}</ref> This allows one of the men to be the biological father while the other will be an adopted father.


Gay men who have become fathers using surrogacy have reported similar experiences to those as other couples who have used surrogacy, including their relationships both their child and their surrogate have.<ref>{{cite journal | vauthors = Blake L, Carone N, Slutsky J, Raffanello E, Ehrhardt AA, Golombok S | title = Gay father surrogacy families: relationships with surrogates and egg donors and parental disclosure of children's origins | journal = Fertility and Sterility | volume = 106 | issue = 6 | pages = 1503–1509 | date = November 2016 | pmid = 27565261 | pmc = 5090043 | doi = 10.1016/j.fertnstert.2016.08.013 }}</ref>
If created, a "female sperm" cell could fertilize an egg cell, a procedure that, among other potential applications, might enable female [[same-sex couple]]s to produce a child who would be the biological offspring of their two mothers. It is also claimed that production of female sperm may stimulate a woman to be both the mother and father (similar to asexual reproduction) of an offspring produced by her own sperm. Many queries, both ethical and moral, arise over these arguments.<ref>{{cite web|url=http://www.ncl.ac.uk/press.office/press.release/item/1176449611|title=Early-stage sperm cells created|publisher=[[Newcastle University]]|date=2007-04-13|url-status=dead|archive-url=https://web.archive.org/web/20131109045059/http://www.ncl.ac.uk/press.office/press.release/item/1176449611|archive-date=2013-11-09}}</ref><ref>{{cite news|url=https://www.telegraph.co.uk/news/uknews/1548492/Women-may-be-able-to-grow-own-sperm.html|title=Women may be able to grow own sperm|date=2007-04-14|publisher=Daily Telegraph | location=London | vauthors = Highfield R | access-date=2010-05-02}}</ref><ref>{{cite news|url=http://pierretristam.com/Bobst/07/wf041307a.htm|title=The prospect of all-female conception|work=[[The Independent]]|date=2007-04-13|location=London| vauthors = Connor S |access-date=2010-05-02|archive-url=https://web.archive.org/web/20110106164544/http://pierretristam.com/Bobst/07/wf041307a.htm|archive-date=2011-01-06|url-status=dead}}</ref><ref>{{cite news|url=https://www.newscientist.com/article/dn11601-bone-stem-cells-turned-into-primitive-sperm-cells.html|title=Bone stem cells turned into primitive sperm cells|publisher=[[New Scientist]]|date=2007-04-13}}</ref>


There is theoretical work being done on creating a [[zygote]] from two men which would enable both men to be biological fathers, but it is yet to be practically implemented.<ref name = "Ringler_2015">{{cite web | vauthors = Ringler G | date = 18 March 2015 |url=https://time.com/3748019/same-sex-couples-biological-children/|title=Get Ready for Embryos From Two Men or Two Women|access-date=4 July 2021}}</ref>
== Transgender women ==
{{main|Transgender pregnancy}}
{{Transgender sidebar|medicine}}


Barrie and Tony Drewitt-Barlow from the United Kingdom became the first gay men in the country to father twins born through surrogacy in 1999.<ref name="Woodward">{{cite news | vauthors = Woodward W |title=Gay couple celebrate birth of twins Aspen and Saffron |url= https://www.theguardian.com/uk/1999/dec/13/willwoodward1 |work=The Guardian |date=13 December 1999}}</ref><ref name="Wakefield">{{cite web | vauthors = Wakefield L |title=Britain's 'first gay dads' expecting triplets with daughter's ex-boyfriend |url=https://www.pinknews.co.uk/2021/12/13/uk-birth-certificates-gay-dads-barrie-tony-drewitt-barlow/ |website=PinkNews |date=13 December 2021}}</ref>
Many [[Trans woman|trans women]] want to have children.<ref>{{Cite web|date=2019-10-02|title=Family Equality {{!}} Trans Women and Fertility: What We Know, What We Don't Know, and What You Can Do|url=https://www.familyequality.org/2019/10/02/trans-women-and-fertility-what-we-know-what-dont-know-and-what-you-can-do/|access-date=2022-02-22|website=Family Equality|language=en-US}}</ref><ref>{{cite web |url=https://www.familyequality.org/wp-content/uploads/2019/02/LGBTQ-Family-Building-Study_Jan2019-1.pdf#page=4 |title=2018 LGBTQ Family Building Survey |date=2019 |website=Family Equality Council}}</ref> Some may seek to have children by using their own sperm and an [[egg donor]] or biological female partner. Fertility can be impeded in a variety of ways due to [[feminizing hormone therapy]].


[[File:Surrogate parents attending birth.jpg|thumb|Surrogate parents attending birth]]Surrogacy is a process in which a woman carries and delivers a child for a couple or an individual. This can be an ''arrangement'' supported by a legal agreement where the surrogate may or may not be compensated. Surrogacy is the most common form of accessing parenthood because it is less complicated due to the biological connection made between parent and child. LGBTQ+ individuals may seek surrogacy when they are in need for someone else to serve as the gestational carrier of their biological child. Recently, traveling for couples outside of the US to seek surrogacy is rising. Usually these commercial services cater only white, wealthy parents-to-be. In some countries it is illegal to pay surrogates, but the debate is that unpaid surrogacy can take place.
Trans women may have lower sperm quality before HRT, which may pose an issue for creating viable sperm samples to freeze.<ref>{{cite journal | vauthors = Li K, Rodriguez D, Gabrielsen JS, Centola GM, Tanrikut C | title = Sperm cryopreservation of transgender individuals: trends and findings in the past decade | journal = Andrology | volume = 6 | issue = 6 | pages = 860–864 | date = November 2018 | pmid = 30094956 | pmc = 6301129 | doi = 10.1111/andr.12527 }}</ref>


Choosing who will be the biological parent can vary from couple to couple because couples get to decide where gametes can come from. Gametes can be purchased through commercial resources, arranged through an agreement from a genetic connection to both parents, or through a friend donation.
Estrogens suppress testosterone levels and at high doses can markedly disrupt sex drive and function and fertility on their own.<ref name="JonesReiter2016">{{cite journal | vauthors = Jones CA, Reiter L, Greenblatt E |title=Fertility preservation in transgender patients |journal=International Journal of Transgenderism |volume=17 |issue=2 |year=2016 |pages=76–82 |issn=1553-2739 |doi=10.1080/15532739.2016.1153992 |s2cid=58849546 |quote=Traditionally, patients have been advised to cryopreserve sperm prior to starting cross-sex hormone therapy as there is a potential for a decline in sperm motility with high-dose estrogen therapy over time (Lubbert et al., 1992). However, this decline in fertility due to estrogen therapy is controversial due to limited studies.}}</ref><ref name="PayneHardy2007">{{cite book | vauthors = Payne AH, Hardy MP |title=The Leydig Cell in Health and Disease |url=https://books.google.com/books?id=x4ttqKIAOg0C&pg=PA422 |date=28 October 2007 |publisher=Springer Science & Business Media |isbn=978-1-59745-453-7 |pages=422–431 |quote=Estrogens are highly efficient inhibitors of the hypothalamic-hypophyseal-testicular axis (212–214). Aside from their negative feedback action at the level of the hypothalamus and pituitary, direct inhibitory effects on the testis are likely (215,216). [...] The histology of the testes [with estrogen treatment] showed disorganization of the seminiferous tubules, vacuolization and absence of lumen, and compartmentalization of spermatogenesis.}}</ref><ref name="Salam2003">{{cite book | vauthors = Salam MA |title=Principles & Practice of Urology: A Comprehensive Text |url=https://books.google.com/books?id=y50kTcCCfEcC&pg=PA684 |year=2003 |publisher=Universal-Publishers |isbn=978-1-58112-412-5 |pages=684– |quote=Estrogens act primarily through negative feedback at the hypothalamic-pituitary level to reduce LH secretion and testicular androgen synthesis. [...] Interestingly, if the treatment with estrogens is discontinued after 3 yr. of uninterrupted exposure, serum testosterone may remain at castration levels for up to another 3 yr. This prolonged suppression is thought to result from a direct effect of estrogens on the Leydig cells.}}</ref><ref name="pmid7500443">{{cite journal | vauthors = Cox RL, Crawford ED | title = Estrogens in the treatment of prostate cancer | journal = The Journal of Urology | volume = 154 | issue = 6 | pages = 1991–8 | date = December 1995 | pmid = 7500443 | doi = 10.1016/S0022-5347(01)66670-9 }}</ref> Moreover, disruption of gonadal function and fertility by estrogens may be permanent after extended exposure.<ref name="Salam2003" /><ref name="pmid7500443" /><ref>{{cite journal | vauthors = Adeleye AJ, Reid G, Kao CN, Mok-Lin E, Smith JF | title = Semen Parameters Among Transgender Women With a History of Hormonal Treatment | language = English | journal = Urology | volume = 124 | pages = 136–141 | date = February 2019 | pmid = 30312673 | doi = 10.1016/j.urology.2018.10.005 | s2cid = 52973277 }}</ref>


There is a long history of transnational surrogacy used by gay parents who seek surrogacy in India. They use gametes fertilized by one or both parents to inseminate local women who are employed through an agency. There is global criticism due to transparency around pay and the outcomes for the parties involved. Because of this surrogacy services in India are being recalled by gay parents because there is restricted access to pregnancy updates. Unable to communicate can create emotional distancing for gay parents and the pregnancy can be stressful for gay parents. Going through surrogate services can be a stressful journey because gay parents are caught up in between charts and graphs, instead of being able to have an emotional connection with the baby through the surrogate and the experiences they go through.
Nonsteroidal antiandrogens like [[bicalutamide]] may be an option for transgender women who wish to preserve [[sex drive]], [[sexual function]], and/or [[fertility]], relative to antiandrogens that suppress testosterone levels and can greatly disrupt these functions such as cyproterone acetate and GnRH modulators.<ref name="pmid29352423">{{cite journal | vauthors = Gao Y, Maurer T, Mirmirani P | title = Understanding and Addressing Hair Disorders in Transgender Individuals | journal = American Journal of Clinical Dermatology | volume = 19 | issue = 4 | pages = 517–527 | date = August 2018 | pmid = 29352423 | doi = 10.1007/s40257-018-0343-z | quote = Non-steroidal antiandrogens include flutamide, nilutamide, and bicalutamide, which do not lower androgen levels and may be favorable for individuals who want to preserve sex drive and fertility [9]. | s2cid = 6467968 }}</ref><ref name="IversenMelezinek2001">{{cite journal | vauthors = Iversen P, Melezinek I, Schmidt A | title = Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function | journal = BJU International | volume = 87 | issue = 1 | pages = 47–56 | date = January 2001 | pmid = 11121992 | doi = 10.1046/j.1464-410x.2001.00988.x | s2cid = 28215804 | doi-access = free }}</ref><ref name="MorganteGradini2001">{{cite journal | vauthors = Morgante E, Gradini R, Realacci M, Sale P, D'Eramo G, Perrone GA, Cardillo MR, Petrangeli E, Russo M, Di Silverio F | display-authors = 6 | title = Effects of long-term treatment with the anti-androgen bicalutamide on human testis: an ultrastructural and morphometric study | journal = Histopathology | volume = 38 | issue = 3 | pages = 195–201 | date = March 2001 | pmid = 11260298 | doi = 10.1046/j.1365-2559.2001.01077.x | hdl = 11573/387981 | s2cid = 36892099 }}</ref> However, estrogens suppress testosterone levels and at high doses can markedly disrupt sex drive and function and fertility on their own.<ref name="JonesReiter20162">{{cite journal | vauthors = Jones CA, Reiter L, Greenblatt E |year=2016 |title=Fertility preservation in transgender patients |journal=International Journal of Transgenderism |volume=17 |issue=2 |pages=76–82 |doi=10.1080/15532739.2016.1153992 |issn=1553-2739 |quote=Traditionally, patients have been advised to cryopreserve sperm prior to starting cross-sex hormone therapy as there is a potential for a decline in sperm motility with high-dose estrogen therapy over time (Lubbert et al., 1992). However, this decline in fertility due to estrogen therapy is controversial due to limited studies. |s2cid=58849546}}</ref><ref name="PayneHardy20072">{{cite book | vauthors = Payne AH, Hardy MP |url=https://books.google.com/books?id=x4ttqKIAOg0C&pg=PA422 |title=The Leydig Cell in Health and Disease |date=28 October 2007 |publisher=Springer Science & Business Media |isbn=978-1-59745-453-7 |pages=422–431 |quote=Estrogens are highly efficient inhibitors of the hypothalamic-hypophyseal-testicular axis (212–214). Aside from their negative feedback action at the level of the hypothalamus and pituitary, direct inhibitory effects on the testis are likely (215,216). [...] The histology of the testes [with estrogen treatment] showed disorganization of the seminiferous tubules, vacuolization and absence of lumen, and compartmentalization of spermatogenesis. |name-list-style=vanc}}</ref><ref name="Salam20032">{{cite book | vauthors = Salam MA |url=https://books.google.com/books?id=y50kTcCCfEcC&pg=PA684 |title=Principles & Practice of Urology: A Comprehensive Text |publisher=Universal-Publishers |year=2003 |isbn=978-1-58112-412-5 |pages=684– |quote=Estrogens act primarily through negative feedback at the hypothalamic-pituitary level to reduce LH secretion and testicular androgen synthesis. [...] Interestingly, if the treatment with estrogens is discontinued after 3 yr. of uninterrupted exposure, serum testosterone may remain at castration levels for up to another 3 yr. This prolonged suppression is thought to result from a direct effect of estrogens on the Leydig cells. |name-list-style=vanc}}</ref><ref name="pmid75004432">{{cite journal | vauthors = Cox RL, Crawford ED | title = Estrogens in the treatment of prostate cancer | journal = The Journal of Urology | volume = 154 | issue = 6 | pages = 1991–1998 | date = December 1995 | pmid = 7500443 | doi = 10.1016/S0022-5347(01)66670-9 }}</ref> Moreover, disruption of gonadal function and fertility by estrogens may be permanent after extended exposure.<ref name="Salam20032" /><ref name="pmid75004432" />


Transnational surrogacy can raise legal issues when the child is born. There is conflict about national legal rules on parentage and this complicates citizenship, which can often result in the child not having legal parents or citizenship in any country.
Some trans women want to carry their own children through [[transgender pregnancy]], which has its own set of issues to be overcome, because transgender women do not naturally have the anatomy needed for embryonic and fetal development. As of 2008, there were no successful cases of [[uterus transplant]]ation concerning a transgender woman.<ref>{{cite news| vauthors = Leith W |date=2008-04-10|title=Pregnant men: hard to stomach?|newspaper=Telegraph|location=London|url=https://www.telegraph.co.uk/men/active/mens-health/3354220/Pregnant-men-hard-to-stomach.html}}</ref>


The World Profession Association for Transgender Health ([[World Professional Association for Transgender Health|WPATH]]) recommends that all transgender patients make decisions regarding their fertility before starting hormone therapy in their ''Standards of Care (2012)'' guidebook for medical professionals.<ref name=":1">{{Cite journal |last1=Jones |first1=C. A. |last2=Reiter |first2=L. |last3=Greenblatt |first3=E. |date=2016-04-02 |title=Fertility preservation in transgender patients |url=http://www.tandfonline.com/doi/full/10.1080/15532739.2016.1153992 |journal=International Journal of Transgenderism |language=en |volume=17 |issue=2 |pages=76–82 |doi=10.1080/15532739.2016.1153992 |s2cid=58849546 |issn=1553-2739}}</ref>
Uterine transplantation, or UTx, is currently in its infancy and is not yet publicly available. As of 2019, in cisgender women, more than 42 UTx procedures had been performed, with 12 live births resulting from the transplanted uteruses as of publication.<ref>{{cite journal | vauthors = Jones BP, Williams NJ, Saso S, Thum MY, Quiroga I, Yazbek J, Wilkinson S, Ghaem-Maghami S, Thomas P, Smith JR | display-authors = 6 | title = Uterine transplantation in transgender women | journal = BJOG | volume = 126 | issue = 2 | pages = 152–156 | date = January 2019 | pmid = 30125449 | pmc = 6492192 | doi = 10.1111/1471-0528.15438 }}</ref> The International Society of Uterine Transplantation (ISUTx) was established internationally in 2016, with 70 clinical doctors and scientists, and currently has 140 intercontinental delegates.<ref>{{Cite web|title=History of ISUTx|url=https://www.isutx.org/about/|work=International Society for Uterus Transplantation (ISUTx)|access-date=2021-07-26|archive-date=2021-11-23|archive-url=https://web.archive.org/web/20211123223505/https://www.isutx.org/about/|url-status=dead}}</ref> Its goal is to, "through scientific innovations, advance medical care in the field of uterus transplantation."<ref>{{Cite web|title=About - 'Vision'|url=https://www.isutx.org/about/#vision-row|work=International Society for Uterus Transplantation (ISUTx)|access-date=2021-07-26|archive-date=2021-11-23|archive-url=https://web.archive.org/web/20211123223505/https://www.isutx.org/about/#vision-row|url-status=dead}}</ref>


=== Transgender men ===
In 2012, [[McGill University]] published the "Montreal Criteria for the Ethical Feasibility of Uterine Transplantation", a proposed set of criteria for carrying out uterine transplants, in ''Transplant International''.<ref name="Montreal">{{cite journal | vauthors = Lefkowitz A, Edwards M, Balayla J | title = The Montreal Criteria for the Ethical Feasibility of Uterine Transplantation | journal = Transplant International | volume = 25 | issue = 4 | pages = 439–47 | date = April 2012 | pmid = 22356169 | doi = 10.1111/j.1432-2277.2012.01438.x | s2cid = 39516819 | doi-access = free }}</ref> Under these criteria, only a [[cisgender]] woman could ethically be considered a transplant recipient. The exclusion of trans women from candidacy may lack justification.<ref>{{cite journal | vauthors = Lefkowitz A, Edwards M, Balayla J | title = Ethical considerations in the era of the uterine transplant: an update of the Montreal Criteria for the Ethical Feasibility of Uterine Transplantation | journal = Fertility and Sterility | volume = 100 | issue = 4 | pages = 924–6 | date = October 2013 | pmid = 23768985 | doi = 10.1016/j.fertnstert.2013.05.026 | quote = However, it certainly bears mentioning that there does not seem to be a prima facie ethical reason to reject the idea of performing uterine transplant on a male or trans patient. A male or trans patient wishing to gestate a child does not have a lesser claim to that desire than their female counterparts. The principle of autonomy is not sex-specific. This right is not absolute, but it is not the business of medicine to decide what is unreasonable to request for a person of sound mind, except as it relates to medical and surgical risk, as well as to distribution of resources. A male who identifies as a woman, for example, arguably has UFI, no functionally different from a woman who is born female with UFI. Irrespective of the surgical challenges involved, such a person's right to self-governance of her reproductive potential ought to be equal to her genetically female peers and should be respected. | doi-access = free }}</ref>
Pregnancy is possible for transgender men who retain a functioning [[vagina]], [[Ovary|ovaries]], and a [[uterus]].<ref name=":4">{{Cite journal |last1=Obedin-Maliver |first1=Juno |last2=Makadon |first2=Harvey J |date=March 2016 |title=Transgender men and pregnancy |journal=Obstetric Medicine |volume=9 |issue=1 |pages=4–8 |doi=10.1177/1753495X15612658 |issn=1753-495X |pmc=4790470 |pmid=27030799}}</ref><ref>{{Cite journal |last1=Leung |first1=Angela |last2=Sakkas |first2=Denny |last3=Pang |first3=Samuel |last4=Thornton |first4=Kim |last5=Resetkova |first5=Nina |date=2019-11-01 |title=Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine |url=https://www.sciencedirect.com/science/article/pii/S0015028219306193 |journal=Fertility and Sterility |volume=112 |issue=5 |pages=858–865 |doi=10.1016/j.fertnstert.2019.07.014 |pmid=31594633 |issn=0015-0282}}</ref> Exposure to hormonal testosterone treatment does not necessarily preclude the possibility live birth.<ref name=":16">{{Cite journal |last1=Douglas |first1=Christopher R. |last2=Phillips |first2=Destiny |last3=Sokalska |first3=Anna |last4=Aghajanova |first4=Lusine |date=2022-05-02 |title=Fertility Preservation for Transgender Males |url=http://dx.doi.org/10.1097/aog.0000000000004751 |journal=Obstetrics & Gynecology |volume=139 |issue=6 |pages=1012–1017 |doi=10.1097/aog.0000000000004751 |pmid=35675598 |s2cid=249332982 |issn=0029-7844}}</ref> Testosterone therapy by itself is not a sufficient method of [[contraception]], and trans men may experience unintended pregnancy<ref name=":3">{{Cite journal |last1=Berger |first1=Anthony P. |last2=Potter |first2=Elizabeth M. |last3=Shutters |first3=Christina M. |last4=Imborek |first4=Katherine L. |date=2015-09-01 |title=Pregnant transmen and barriers to high quality healthcare |url=https://pubs.lib.uiowa.edu/pog/article/id/3565/ |journal=Proceedings in Obstetrics and Gynecology |language=en |volume=5 |issue=2 |pages=1–12 |doi=10.17077/2154-4751.1285 |issn=2154-4751}}</ref><ref>{{Cite journal |last1=Light |first1=Alexis |last2=Wang |first2=Lin-Fan |last3=Zeymo |first3=Alexander |last4=Gomez-Lobo |first4=Veronica |date=2018-10-01 |title=Family planning and contraception use in transgender men |url=https://www.sciencedirect.com/science/article/pii/S0010782418302221 |journal=Contraception |volume=98 |issue=4 |pages=266–269 |doi=10.1016/j.contraception.2018.06.006 |pmid=29944875 |s2cid=49434157 |issn=0010-7824}}</ref> especially if they miss doses.<ref name=":3" /> Many trans men who have become pregnant were able to do so within six months of stopping testosterone.<ref name=":3" />  Another study conducted in 2019 found that transgender male patients seeking oocyte retrieval for either oocyte cryopreservation, embryo cryopreservation, or IVF were able to undergo treatment 4 months after stopping testosterone treatment, on average.<ref>{{Cite journal |last1=Leung |first1=Angela |last2=Sakkas |first2=Denny |last3=Pang |first3=Samuel |last4=Thornton |first4=Kim |last5=Resetkova |first5=Nina |date=2019-11-01 |title=Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine |url=https://www.sciencedirect.com/science/article/pii/S0015028219306193 |journal=Fertility and Sterility |volume=112 |issue=5 |pages=858–865 |doi=10.1016/j.fertnstert.2019.07.014 |pmid=31594633 |issn=0015-0282}}</ref> There have been no studies of transgender men attempting pregnancy after testosterone or on the health of offspring conceived from testosterone-exposed oocytes, so exact fertility rates are unknown.<ref name=":8">{{Cite journal |last=Moravek |first=Molly B. |date=June 2019 |title=Fertility preservation options for transgender and gender-nonconforming individuals |url=https://journals.lww.com/co-obgyn/abstract/2019/06000/fertility_preservation_options_for_transgender_and.6.aspx |journal=Current Opinion in Obstetrics and Gynecology |language=en-US |volume=31 |issue=3 |pages=170–176 |doi=10.1097/GCO.0000000000000537 |pmid=30870185 |s2cid=78091839 |issn=1040-872X}}</ref><ref name=":4" />


Masculinizing hormonal therapy in trans men will lead to irreversible [[amenorrhea]], however androgen therapy does not deplete primordial follicles nor affects the developmental capacity of the follicles, but histologically hyperplasia of ovarian cortex and stroma has been found.<ref name=":2">{{Cite journal |last1=T'Sjoen |first1=Guy |last2=Van Caenegem |first2=Eva |last3=Wierckx |first3=Katrien |date=December 2013 |title=Transgenderism and reproduction |url=https://journals.lww.com/01266029-201312000-00013 |journal=Current Opinion in Endocrinology, Diabetes & Obesity |language=en |volume=20 |issue=6 |pages=575–579 |doi=10.1097/01.med.0000436184.42554.b7 |pmid=24468761 |s2cid=205398449 |issn=1752-296X}}</ref> It has been debated if this is physiologically comparable to [[polycystic ovary syndrome]].<ref name=":2" /> [[Oophorectomy|Ovariectomies]] lead to irreversible fertility termination (if the eggs are not stored), but doesn't preclude gestational pregnancy with ART.<ref name=":2" /><ref name=":4" /> Hysterectomies will eliminate the option to gestate.<ref name=":4" />
In addition, if trans women wish to conceive with a biological male partner, they face the same issues that cisgender gay couples have in creating a zygote.


For preservation of reproductive possibilities:
Only 3% of transgender people take efforts to preserve their fertility in transition<ref>{{cite journal | vauthors = Nahata L, Tishelman AC, Caltabellotta NM, Quinn GP | title = Low Fertility Preservation Utilization Among Transgender Youth | journal = The Journal of Adolescent Health | volume = 61 | issue = 1 | pages = 40–44 | date = July 2017 | pmid = 28161526 | doi = 10.1016/j.jadohealth.2016.12.012 | doi-access = free }}</ref> 51% of trans women express regrets for not preserving their fertility,<ref>{{Cite web|date=2021-06-30|title=IJ TRANSGENDER - The Desire to have Children and the Preservation of Fertility in Transsexual Women: A Survey|url=https://cdn.atria.nl/ezines/web/IJT/97-03/numbers/symposion/ijtvo06no03_02.htm|access-date=2022-02-23|archive-url=https://web.archive.org/web/20210630094304/https://cdn.atria.nl/ezines/web/IJT/97-03/numbers/symposion/ijtvo06no03_02.htm|archive-date=2021-06-30}}</ref> and 97% of transgender adults believe it should be discussed before transition.<ref>{{Cite web|title=Many transgender individuals consider their fertility important, survey shows|url=https://www.endocrine.org/news-and-advocacy/news-room/2017/many-transgender-individuals-consider-their-fertility-important-survey-shows|access-date=2022-02-23|website=www.endocrine.org|language=en}}</ref>

=== Transfeminine lactation ===
# Oocyte banking: Cryopreservation of [[Oocyte|oocytes]] requires hormonal stimulation and oocyte retrieval, as for IVF treatment, after which the oocytes are [[Vitrification|vitrified]].<ref name=":2" /> Vitrification of oocytes has been found to be more successful than slow freezing oocytes.<ref>{{Cite journal |last1=Herrero |first1=Leyre |last2=Martínez |first2=Mónica |last3=Garcia-Velasco |first3=Juan A. |date=August 2011 |title=Current status of human oocyte and embryo cryopreservation |url=https://journals.lww.com/co-obgyn/abstract/2011/08000/current_status_of_human_oocyte_and_embryo.7.aspx |journal=Current Opinion in Obstetrics and Gynecology |language=en-US |volume=23 |issue=4 |pages=245–250 |doi=10.1097/GCO.0b013e32834874e2 |pmid=21734500 |s2cid=32837692 |issn=1040-872X}}</ref> The success of oocyte banking declines significantly with increasing reproductive age<ref name=":1" /> Ovarian stimulation will increase transgender men's serum estradiol levels, and in response transvaginal ultrasound monitoring may be necessary, strategies to minimize estradiol elevations include the concomitant use of aromatase inhibitors during stimulation.<ref name=":8" /> There is no data on the success of ovarian stimulation in transgender men who previously had puberty halted with GnRH agonist, followed directly by testosterone administration.<ref name=":8" /> There is also no data comparing the number of oocytes retrieved or the live-birth rate after fertility preservation stratified by time off testosterone.<ref name=":16" />
#* Results with oocytes vitrification (viability, fertilization and pregnancy) have been improving.
# Embryo banking: Freezing of embryos is a possibility; but requires the use of available sperm for embryo creation. Preservation of embryos is common high efficiency procedure performed at fertility centers.<ref name=":2" />
# Banking of ovarian tissue: A surgical procedure is required to collect tissue samples, if undergoing a [[hysterectomy]] and/or ovariectomy, one can choose to cryopreserve some tissue at the same time to avoid an additional surgical procedure.<ref name=":2" /> Ovarian tissue cryopreservation has been successful, but so far, there have been no pregnancies recorded after thawing and in-vitro maturation (IVM) of this tissue, successful pregnancies have only been recorded after [[Autotransplantation|auto-transplantation]].<ref>{{Cite journal |last1=Donnez |first1=J |last2=Dolmans |first2=MM |last3=Demylle |first3=D |last4=Jadoul |first4=P |last5=Pirard |first5=C |last6=Squifflet |first6=J |last7=Martinez-Madrid |first7=B |last8=Van Langendonckt |first8=A |date=October 2004 |title=Livebirth after orthotopic transplantation of cryopreserved ovarian tissue |url=https://doi.org/10.1016/S0140-6736(04)17222-X |journal=The Lancet |volume=364 |issue=9443 |pages=1405–1410 |doi=10.1016/s0140-6736(04)17222-x |pmid=15488215 |s2cid=21448970 |issn=0140-6736}}</ref><ref name=":2" /> This method has a very low success rate of [[blastocyst]] development as in one study of 83 transgender males, 2 out of the 208 mature oocytes were recovered from thawed ovarian tissue created "good-quality" blastocysts.<ref name=":16" />

=== Transgender women ===
Some transgender women have reported a lower sexual desire on hormonal treatment.<ref>{{Cite journal |last1=Wierckx |first1=Katrien |last2=Van Caenegem |first2=Eva |last3=Schreiner |first3=Thomas |last4=Haraldsen |first4=Ira |last5=Fisher |first5=Alessandra |last6=Toye |first6=Kaatje |last7=Kaufman |first7=Jean Marc |last8=T'Sjoen |first8=Guy |date=August 2014 |title=Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short-Time Follow-Up: Results from the European Network for the Investigation of Gender Incongruence |url=http://dx.doi.org/10.1111/jsm.12571 |journal=The Journal of Sexual Medicine |volume=11 |issue=8 |pages=1999–2011 |doi=10.1111/jsm.12571 |pmid=24828032 |hdl=2158/1060207 |issn=1743-6095}}</ref> It has been found that transgender patients undergoing feminizing hormonal therapy do have abnormal semen parameters.<ref>{{Cite journal |last1=Li |first1=Kai |last2=Rodriguez |first2=Dayron |last3=Gabrielsen |first3=J. Scott |last4=Centola |first4=Grace M. |last5=Tanrikut |first5=Cigdem |date=November 2018 |title=Sperm Cryopreservation of Transgender Individuals: Trends and Findings in the Past Decade |journal=Andrology |volume=6 |issue=6 |pages=860–864 |doi=10.1111/andr.12527 |issn=2047-2919 |pmc=6301129 |pmid=30094956}}</ref><ref>{{Cite journal |last1=Adeleye |first1=Amanda J. |last2=Reid |first2=Garrett |last3=Kao |first3=Chia-Ning |last4=Mok-Lin |first4=Evelyn |last5=Smith |first5=James F. |date=2019-02-01 |title=Semen Parameters Among Transgender Women With a History of Hormonal Treatment |url=https://www.sciencedirect.com/science/article/pii/S0090429518310872 |journal=Urology |volume=124 |pages=136–141 |doi=10.1016/j.urology.2018.10.005 |pmid=30312673 |s2cid=52973277 |issn=0090-4295}}</ref> Sustained hormonal treatment eventually leads to hypo-spermatogenesis and ultimately [[azoospermia]] which will become irreversible at an unknown point in time.<ref name=":2" /><ref>{{Cite journal |last1=Rowlands |first1=Sam |last2=Amy |first2=Jean-Jacques |date=2018-01-02 |title=Preserving the reproductive potential of transgender and intersex people |url=https://www.tandfonline.com/doi/full/10.1080/13625187.2017.1422240 |journal=The European Journal of Contraception & Reproductive Health Care |language=en |volume=23 |issue=1 |pages=58–63 |doi=10.1080/13625187.2017.1422240 |pmid=29323576 |s2cid=3784307 |issn=1362-5187}}</ref><ref name=":15">{{Cite journal |date=2020-09-01 |title=Fertility preservation rates among transgender women compared with transgender men receiving comprehensive fertility counselling |url=https://www.sciencedirect.com/science/article/abs/pii/S1472648320302704 |journal=Reproductive BioMedicine Online |language=en-US |volume=41 |issue=3 |pages=546–554 |doi=10.1016/j.rbmo.2020.05.003 |issn=1472-6483 |last1=Amir |first1=Hadar |last2=Yaish |first2=Iris |last3=Oren |first3=Asaf |last4=Groutz |first4=Asnat |last5=Greenman |first5=Yona |last6=Azem |first6=Foad |pmid=32651108 |s2cid=219435735 }}</ref> A 2015 study did demonstrate normal spermatogenesis in long term estrogen therapy patients.<ref name=":1" /> Surgical removal of testicles also leads to irreversible sterility.<ref name=":2" /><ref name=":15" /> It is recommended for those pursing these options and interested in preserving fertility to cryogenically store their sperm before starting their treatment.<ref name=":2" />
Semen can be collected via masturbation, but there are alternatives for those who find masturbation or ejaculation distressing or may have erectile or [[Sexual dysfunction|ejaculatory dysfunction]] secondary to [[Androgen deficiency|hypoandrogenism]]. Options for those with dysfunction include: [[Vibroejaculation|penile vibratory stimulation]] and [[electroejaculation]].<ref name=":8" /> For those who do not want to ejaculate or have oligospermia or azoospermia can pursue [[Testicular sperm extraction|testicular sperm aspiration]] or microsurgical sperm extraction although they are more invasive.<ref name=":8" /> There are currently no studies evaluating the acceptability or success rates of the different options for sperm collection specifically in transgender women.<ref name=":8" /> Furthermore, for transgender women on estradiol and/or antiandrogens, it is unclear the length of time needed to be off hormonal treatment medication before normal spermatogenesis resumes (if it occurs at all), during which time testosterone production will resume and may cause unwanted masculinizing effects.<ref name=":8" />

== Body-feeding ==
The term body-feeding refers to the feeding of one's baby milk to an infant directly from one's body.<ref>{{Cite web |date=2021-06-09 |title=It's time to add "chestfeeding" to your vocabulary |url=https://www.todaysparent.com/baby/breastfeeding/chestfeeding-faq/ |access-date=2023-12-04 |website=Today's Parent |language=en}}</ref> Body-feeding is essential for the development of infants.<ref>{{Cite web |title=Rates of breastfeeding or chestfeeding and influencing factors among transgender and gender-diverse parents: a cross sectional study |url=sciencedirect.com/science/article/pii/S258953702300024X}}</ref> Though there is a large transgender and gender diverse population, the quantitative and qualitative research regarding body-feeding is relatively small.<ref>{{Cite journal |title=Rates of breastfeeding or chestfeeding and influencing factors among transgender and gender-diverse parents: a cross sectional study |date=2023 |doi=10.1016/j.eclinm.2023.101847 |last1=Yang |first1=Haibing |last2=Na |first2=Xiaona |last3=Zhang |first3=Yanwen |last4=Xi |first4=Menglu |last5=Yang |first5=Yucheng |last6=Chen |first6=Runsen |last7=Zhao |first7=Ai |journal=eClinicalMedicine |volume=57 |pmid=36864982 |pmc=9971548 }}</ref> Though widely known as [[breastfeeding]], new gender-affirming terms have developed: body-feeding and chest-feeding. These terms took note after transgender males (female to male) found discomfort in the terms "breastfeeding" and "[[lactation]]".

Studies done on the breastfeeding or chestfeeding practices of transgender or gender diverse parents are extremely limited. A study done focused on the socio-demographic characteristics among parents with different breastfeeding or chestfeeding practices shows that mixed/artificial feeding (the use of formula and breast (or chest) milk) is widely used for families with higher annual incomes (100-200k) with 73.0% utilizing mixed/artificial feeding.<ref>{{Cite journal |title=Rates of breastfeeding or chestfeeding and influencing factors among transgender and gender-diverse parents: a cross sectional study |date=2023 |doi=10.1016/j.eclinm.2023.101847 |last1=Yang |first1=Haibing |last2=Na |first2=Xiaona |last3=Zhang |first3=Yanwen |last4=Xi |first4=Menglu |last5=Yang |first5=Yucheng |last6=Chen |first6=Runsen |last7=Zhao |first7=Ai |journal=eClinicalMedicine |volume=57 |pmid=36864982 |pmc=9971548 }}</ref> Results from this study show that most transgender or gender diverse populations prefer mixed/artificial feedings instead of exclusive chestfeeding.<ref>{{Cite journal |title=Rates of breastfeeding or chestfeeding and influencing factors among transgender and gender-diverse parents: a cross sectional study |date=2023 |doi=10.1016/j.eclinm.2023.101847 |last1=Yang |first1=Haibing |last2=Na |first2=Xiaona |last3=Zhang |first3=Yanwen |last4=Xi |first4=Menglu |last5=Yang |first5=Yucheng |last6=Chen |first6=Runsen |last7=Zhao |first7=Ai |journal=eClinicalMedicine |volume=57 |pmid=36864982 |pmc=9971548 }}</ref>

== Lactation as a transwoman ==
{{medical citations needed|section|date=April 2022}}{{See also|Male lactation|Colostrum}}
{{medical citations needed|section|date=April 2022}}{{See also|Male lactation|Colostrum}}


Line 57: Line 105:
To induce lactation, domperidone is used at a dosage of 10 to 20&nbsp;mg 3 or 4 times per day by mouth.<ref name="Henderson2003">{{cite journal | vauthors = Henderson A | title = Domperidone. Discovering new choices for lactating mothers | journal = AWHONN Lifelines | volume = 7 | issue = 1 | pages = 54–60 | year = 2003 | pmid = 12674062 | doi = 10.1177/1091592303251726 }}</ref> Effects may be seen within 24 hours or after 3 or 4 days.<ref name="Henderson2003" /> The maximum effect occurs after 2 or 3 weeks of treatment, and the treatment period generally lasts for 3 to 8 weeks.<ref name="Henderson2003" />
To induce lactation, domperidone is used at a dosage of 10 to 20&nbsp;mg 3 or 4 times per day by mouth.<ref name="Henderson2003">{{cite journal | vauthors = Henderson A | title = Domperidone. Discovering new choices for lactating mothers | journal = AWHONN Lifelines | volume = 7 | issue = 1 | pages = 54–60 | year = 2003 | pmid = 12674062 | doi = 10.1177/1091592303251726 }}</ref> Effects may be seen within 24 hours or after 3 or 4 days.<ref name="Henderson2003" /> The maximum effect occurs after 2 or 3 weeks of treatment, and the treatment period generally lasts for 3 to 8 weeks.<ref name="Henderson2003" />


== Barriers to fertility care ==
== Transgender men ==
=== Economic ===
Fertility treatment and preservation is expensive. The average IVF cycle can cost $12,000 to $17,000 (not including medication), with medication it can up to $25,000-$30,000 <ref>{{Cite news |last=Klein |first=Amy |date=2020-04-18 |title=I.V.F. is Expensive. Here's How to Bring Down the Cost. |language=en-US |work=The New York Times |url=https://www.nytimes.com/article/ivf-treatment-costs-guide.html |access-date=2023-12-04 |issn=0362-4331}}</ref><ref name=":22">{{Cite web |date=2021-09-28 |title=How Much Does IVF Cost? |url=https://www.forbes.com/health/womens-health/how-much-does-ivf-cost/ |access-date=2023-12-04 |website=Forbes Health |language=en-US}}</ref> and price often comes down to one's insurance which might come with come with stipulations. The cost of IUI ranges from $500-4,000 per cycle.<ref>{{Cite news |last=Snider |first=Susannah |date=September 29, 2020 |title="How Much Does IUI Cost and How Do I Pay for It?" |work=U.S. News |url=https://money.usnews.com/money/personal-finance/family-finance/articles/how-much-does-iui-cost-and-how-do-i-pay-for-it }}</ref> Cryopreservation of genetic material is also costly see table below and can vary greatly from place to place, state to state.<ref name=":21">{{Cite web |title=Paying For Treatments |url=https://www.allianceforfertilitypreservation.org/paying-for-treatments/ |access-date=2023-12-04 |website=Alliance for Fertility Preservation |language=en-US}}</ref>
{| class="wikitable"
|+
!Fertility preservation Option
!Service Cost Range ($)
!Annual Storage Cost Range ($)
|-
|Egg Freezing
|7,000-15,000
|300-1000<ref name=":21" /><ref>{{Cite web |last=PFCLA |title=Cost of Egg & Embryo Freezing in the U.S. {{!}} PFCLA |url=https://www.pfcla.com/blog/egg-freezing-costs |access-date=2023-12-04 |website=www.pfcla.com |language=en}}</ref>
|-
|Embryo freezing
|11,000-15,000
|350-600<ref name=":22" />
|-
|Ovarian Tissue Freezing
|10,000-12,000
|300-500
|-
|Sperm Banking
|250-1,000<ref>{{Cite web |date=2022-12-01 |title=How Much Does It Cost To Freeze Sperm? |url=https://www.forbes.com/health/family/freeze-sperm-cost/ |access-date=2023-12-04 |website=Forbes Health |language=en-US}}</ref>
|100-500<ref>{{Cite web |date=2021-11-02 |title=Sperm Banking |url=https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/sperm-banking |access-date=2023-12-04 |website=www.hopkinsmedicine.org |language=en}}</ref>
|-
|Testicular Sperm Extraction
|7,500-10,000
|300-500
|-
|Electroejaculation
|10,000-12,000
|300-500
|}
Another barrier is knowledge. These procedures are not well known and discussion of fertility preservation are uncommon. In a study of 133 transgender women 61% stated that no health care provider discussed sperm banking prior to their hormone therapy or surgery.<ref>{{Cite journal |last1=Asafu-Adjei* |first1=Denise |last2=Caputo |first2=Joseph M. |last3=Bockting |first3=Walter O. |last4=Diah |first4=Jonathan |last5=Alukal |first5=Joseph |last6=Stahl |first6=Peter J. |date=April 2020 |title=MP26-16 Mismatch Between Attitudes Towards Fertility and Clinical Care for Fertility Preservation in Transgender Women: Data From Project Affirm |url=http://dx.doi.org/10.1097/ju.0000000000000865.016 |journal=Journal of Urology |volume=203 |issue=Supplement 4 |doi=10.1097/ju.0000000000000865.016 |issn=0022-5347}}</ref> In another study, 70 transgender males cited barriers such as the perceived cost of treatment (36%), need for discontinuation or delay of hormonal therapy (19%), and worsening gender dysphoria with treatment and pregnancy (11%).<ref name=":16" />


=== Physical ===
{{main|Transgender pregnancy}}
Only 3% of transgender people take efforts to preserve their fertility in transition<ref>{{cite journal | vauthors = Nahata L, Tishelman AC, Caltabellotta NM, Quinn GP | title = Low Fertility Preservation Utilization Among Transgender Youth | journal = The Journal of Adolescent Health | volume = 61 | issue = 1 | pages = 40–44 | date = July 2017 | pmid = 28161526 | doi = 10.1016/j.jadohealth.2016.12.012 | doi-access = free }}</ref> 51% of trans women express regrets for not preserving their fertility,<ref>{{Cite web|date=2021-06-30|title=IJ TRANSGENDER - The Desire to have Children and the Preservation of Fertility in Transsexual Women: A Survey|url=https://cdn.atria.nl/ezines/web/IJT/97-03/numbers/symposion/ijtvo06no03_02.htm|access-date=2022-02-23|archive-url=https://web.archive.org/web/20210630094304/https://cdn.atria.nl/ezines/web/IJT/97-03/numbers/symposion/ijtvo06no03_02.htm|archive-date=2021-06-30}}</ref> and 97% of transgender adults believe it should be discussed before transition.<ref>{{Cite web|title=Many transgender individuals consider their fertility important, survey shows|url=https://www.endocrine.org/news-and-advocacy/news-room/2017/many-transgender-individuals-consider-their-fertility-important-survey-shows|access-date=2022-02-23|website=www.endocrine.org|language=en}}</ref>

[[Trans man|Transgender men]] have a unique situation when it comes to LGBT reproduction as they are one of the only groups that has a risk of [[unintended pregnancy]] in a same-gender relationship (cisgender lesbians in relationships with fertile trans women being another example).<ref name="Berger" /><ref name="light-2018a" /> Pregnancy is possible for transgender men who retain a functioning [[vagina]], [[ovary|ovaries]], and a [[uterus]].<ref>{{cite journal | vauthors = Obedin-Maliver J, Makadon HJ | title = Transgender men and pregnancy | journal = Obstetric Medicine | volume = 9 | issue = 1 | pages = 4–8 | date = March 2016 | pmid = 27030799 | pmc = 4790470 | doi = 10.1177/1753495X15612658 }}</ref><ref>{{cite book | vauthors = Beatie T |title=Labor of love : the story of one mans extraordinary pregnancy |date = 14 March 2008 |publisher=Seal Press |location=Berkeley |isbn=978-1-58005-300-6}}</ref><ref name="Advocate">{{cite magazine | vauthors = Beatie T |title=Labor of Love: Is society ready for this pregnant husband? | url = https://www.advocate.com/news/2008/03/14/labor-love |magazine=[[The Advocate (LGBT magazine)|The Advocate]]|date=April 8, 2008|page=24}}</ref><ref name="leung-2019a">{{cite journal | vauthors = Leung A, Sakkas D, Pang S, Thornton K, Resetkova N | title = Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine | language = English | journal = Fertility and Sterility | volume = 112 | issue = 5 | pages = 858–865 | date = November 2019 | pmid = 31594633 | doi = 10.1016/j.fertnstert.2019.07.014 | s2cid = 203983887 | doi-access = free }}</ref>


Testosterone therapy affects fertility, but many trans men who have become pregnant were able to do so within six months of stopping testosterone. <ref name="Berger">{{Cite journal | doi=10.17077/2154-4751.1285| title=Pregnant transmen and barriers to high quality healthcare| year=2015| vauthors = Berger AP, Potter EM, Shutters CM, Imborek KL | journal=Proceedings in Obstetrics and Gynecology| volume=5| issue=2| pages=1–12| doi-access=free}}</ref> Another study conducted in 2019 found that transgender male patients seeking oocyte retrieval for either oocyte cryopreservation, embryo cryopreservation, or IVF were able to undergo treatment 4 months after stopping testosterone treatment, on average.<ref name="leung-2019a" /> All patients experienced menses and normal AMH, FSH, and E<sub>2</sub> levels and antral follicle counts after coming off testosterone which allowed for successful oocyte retrieval.<ref name="leung-2019a" /> Although the long-term effects of androgen treatment on fertility is still widely unknown, oocyte retrieval does not appear to be affected. Future pregnancies can be achieved by [[oophyte banking]], but the process may increase gender dysphoria or may not be accessible due to lack of insurance coverage.<ref name="Berger" /> Testosterone therapy is not a sufficient method of [[contraception]], and trans men may experience unintended pregnancy,<ref name="Berger" /><ref name="light-2018a">{{cite journal | vauthors = Light A, Wang LF, Zeymo A, Gomez-Lobo V | title = Family planning and contraception use in transgender men | journal = Contraception | volume = 98 | issue = 4 | pages = 266–269 | date = October 2018 | pmid = 29944875 | doi = 10.1016/j.contraception.2018.06.006 | s2cid = 49434157 }}</ref> especially if they miss doses.<ref name="Berger" />
Testosterone therapy affects fertility, but many trans men who have become pregnant were able to do so within six months of stopping testosterone. <ref name="Berger">{{Cite journal | doi=10.17077/2154-4751.1285| title=Pregnant transmen and barriers to high quality healthcare| year=2015| vauthors = Berger AP, Potter EM, Shutters CM, Imborek KL | journal=Proceedings in Obstetrics and Gynecology| volume=5| issue=2| pages=1–12| doi-access=free}}</ref> Another study conducted in 2019 found that transgender male patients seeking oocyte retrieval for either oocyte cryopreservation, embryo cryopreservation, or IVF were able to undergo treatment 4 months after stopping testosterone treatment, on average.<ref name="leung-2019a" /> All patients experienced menses and normal AMH, FSH, and E<sub>2</sub> levels and antral follicle counts after coming off testosterone which allowed for successful oocyte retrieval.<ref name="leung-2019a" /> Although the long-term effects of androgen treatment on fertility is still widely unknown, oocyte retrieval does not appear to be affected. Future pregnancies can be achieved by [[oophyte banking]], but the process may increase gender dysphoria or may not be accessible due to lack of insurance coverage.<ref name="Berger" /> Testosterone therapy is not a sufficient method of [[contraception]], and trans men may experience unintended pregnancy,<ref name="Berger" /><ref name="light-2018a">{{cite journal | vauthors = Light A, Wang LF, Zeymo A, Gomez-Lobo V | title = Family planning and contraception use in transgender men | journal = Contraception | volume = 98 | issue = 4 | pages = 266–269 | date = October 2018 | pmid = 29944875 | doi = 10.1016/j.contraception.2018.06.006 | s2cid = 49434157 }}</ref> especially if they miss doses.<ref name="Berger" />

Many gay transgender men choose to freeze their eggs before transitioning, and choose to have a female surrogate carry their child while when the time comes, using their eggs and their cis male partner's sperm. This allows them to avoid the potentially dysphoria inducing experience of pregnancy, or cessation of HRT for collecting eggs at an older age.<ref>{{Cite web | vauthors = Compton J | date = 5 March 2019 |title=Transgender men, eager to have biological kids, are freezing their eggs|url=https://www.nbcnews.com/feature/nbc-out/transgender-men-eager-have-biological-kids-are-freezing-their-eggs-n975331|access-date=2021-07-05|website=NBC News|language=en}}</ref><ref>{{Cite web|title=The T-Male: IVF and Surrogacy|url=http://www.thetransitionalmale.com/Surrogate.html|access-date=2021-07-05|website=www.thetransitionalmale.com}}</ref>


Some studies report a higher incidence of [[polycystic ovary syndrome]] (PCOS) among transgender men prior to taking [[testosterone]],<ref>{{cite journal | vauthors = Baba T, Endo T, Honnma H, Kitajima Y, Hayashi T, Ikeda H, Masumori N, Kamiya H, Moriwaka O, Saito T | display-authors = 6 | title = Association between polycystic ovary syndrome and female-to-male transsexuality | journal = Human Reproduction | volume = 22 | issue = 4 | pages = 1011–1016 | date = April 2007 | pmid = 17166864 | doi = 10.1093/humrep/del474 | citeseerx = 10.1.1.519.7356 }}</ref><ref>{{cite journal | vauthors = Becerra-Fernández A, Pérez-López G, Román MM, Martín-Lazaro JF, Lucio Pérez MJ, Asenjo Araque N, Rodríguez-Molina JM, Berrocal Sertucha MC, Aguilar Vilas MV | display-authors = 6 | title = Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals | language = es | journal = Endocrinologia y Nutricion | volume = 61 | issue = 7 | pages = 351–358 | date = August 2014 | pmid = 24680383 | doi = 10.1016/j.endonu.2014.01.010 | s2cid = 162299777 | trans-title = Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals }}</ref><ref>{{cite journal | vauthors = Balen AH, Schachter ME, Montgomery D, Reid RW, Jacobs HS | title = Polycystic ovaries are a common finding in untreated female to male transsexuals | journal = Clinical Endocrinology | volume = 38 | issue = 3 | pages = 325–329 | date = March 1993 | pmid = 8458105 | doi = 10.1111/j.1365-2265.1993.tb01013.x | s2cid = 72741370 }}</ref> the disease causes infertility and can make it harder for trans men to freeze eggs,<ref name="NICHD What are the symptoms of PCOS?">{{cite web|title=What are the symptoms of PCOS?|url=https://www.nichd.nih.gov/health/topics/pcos/conditioninfo/symptoms|website=[[Eunice Kennedy Shriver National Institute of Child Health and Human Development]]}}</ref> though not all have not found the same association of trans men and PCOS.<ref name="Sweden">{{cite journal | vauthors = Cesta CE, Månsson M, Palm C, Lichtenstein P, Iliadou AN, Landén M | title = Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort | journal = Psychoneuroendocrinology | volume = 73 | pages = 196–203 | date = November 2016 | pmid = 27513883 | doi = 10.1016/j.psyneuen.2016.08.005 | hdl-access = free | s2cid = 207460386 | hdl = 10616/45608 }}</ref> People with PCOS in general are also reportedly more likely to see themselves as "sexually undifferentiated" or "androgynous" and "less likely to identify with a female gender scheme."<ref>{{cite journal | vauthors = Kowalczyk R, Skrzypulec V, Lew-Starowicz Z, Nowosielski K, Grabski B, Merk W | title = Psychological gender of patients with polycystic ovary syndrome | journal = Acta Obstetricia et Gynecologica Scandinavica | volume = 91 | issue = 6 | pages = 710–714 | date = June 2012 | pmid = 22443151 | doi = 10.1111/j.1600-0412.2012.01408.x | s2cid = 25055401 | doi-access = free }}</ref><ref name="Sweden" />
Some studies report a higher incidence of [[polycystic ovary syndrome]] (PCOS) among transgender men prior to taking [[testosterone]],<ref>{{cite journal | vauthors = Baba T, Endo T, Honnma H, Kitajima Y, Hayashi T, Ikeda H, Masumori N, Kamiya H, Moriwaka O, Saito T | display-authors = 6 | title = Association between polycystic ovary syndrome and female-to-male transsexuality | journal = Human Reproduction | volume = 22 | issue = 4 | pages = 1011–1016 | date = April 2007 | pmid = 17166864 | doi = 10.1093/humrep/del474 | citeseerx = 10.1.1.519.7356 }}</ref><ref>{{cite journal | vauthors = Becerra-Fernández A, Pérez-López G, Román MM, Martín-Lazaro JF, Lucio Pérez MJ, Asenjo Araque N, Rodríguez-Molina JM, Berrocal Sertucha MC, Aguilar Vilas MV | display-authors = 6 | title = Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals | language = es | journal = Endocrinologia y Nutricion | volume = 61 | issue = 7 | pages = 351–358 | date = August 2014 | pmid = 24680383 | doi = 10.1016/j.endonu.2014.01.010 | s2cid = 162299777 | trans-title = Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals }}</ref><ref>{{cite journal | vauthors = Balen AH, Schachter ME, Montgomery D, Reid RW, Jacobs HS | title = Polycystic ovaries are a common finding in untreated female to male transsexuals | journal = Clinical Endocrinology | volume = 38 | issue = 3 | pages = 325–329 | date = March 1993 | pmid = 8458105 | doi = 10.1111/j.1365-2265.1993.tb01013.x | s2cid = 72741370 }}</ref> the disease causes infertility and can make it harder for trans men to freeze eggs,<ref name="NICHD What are the symptoms of PCOS?">{{cite web|title=What are the symptoms of PCOS?|url=https://www.nichd.nih.gov/health/topics/pcos/conditioninfo/symptoms|website=[[Eunice Kennedy Shriver National Institute of Child Health and Human Development]]}}</ref> though not all have not found the same association of trans men and PCOS.<ref name="Sweden">{{cite journal | vauthors = Cesta CE, Månsson M, Palm C, Lichtenstein P, Iliadou AN, Landén M | title = Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort | journal = Psychoneuroendocrinology | volume = 73 | pages = 196–203 | date = November 2016 | pmid = 27513883 | doi = 10.1016/j.psyneuen.2016.08.005 | hdl-access = free | s2cid = 207460386 | hdl = 10616/45608 }}</ref> People with PCOS in general are also reportedly more likely to see themselves as "sexually undifferentiated" or "androgynous" and "less likely to identify with a female gender scheme."<ref>{{cite journal | vauthors = Kowalczyk R, Skrzypulec V, Lew-Starowicz Z, Nowosielski K, Grabski B, Merk W | title = Psychological gender of patients with polycystic ovary syndrome | journal = Acta Obstetricia et Gynecologica Scandinavica | volume = 91 | issue = 6 | pages = 710–714 | date = June 2012 | pmid = 22443151 | doi = 10.1111/j.1600-0412.2012.01408.x | s2cid = 25055401 | doi-access = free }}</ref><ref name="Sweden" />


== In popular culture ==
== ==
There is theoretical potential for same sex reproduction using [[Stem cell|stem cells]] to derive [[Gamete|gametes]] to produce biologically related children,<ref name=":14">{{Cite journal |last1=Segers |first1=Seppe |last2=Mertes |first2=Heidi |last3=Pennings |first3=Guido |last4=de Wert |first4=Guido |last5=Dondorp |first5=Wybo |date=2017-01-25 |title=Using stem cell-derived gametes for same-sex reproduction: an alternative scenario |url=http://dx.doi.org/10.1136/medethics-2016-103863 |journal=Journal of Medical Ethics |volume=43 |issue=10 |pages=688–691 |doi=10.1136/medethics-2016-103863 |pmid=28122990 |s2cid=35387886 |issn=0306-6800}}</ref> but this has been contentious<ref>{{Cite journal |last1=Adashi |first1=Eli Y. |last2=Cohen |first2=I. Glenn |date=2020-11-15 |title=Assisted Same-Sex Reproduction: The Promise of Haploid Stem Cells? |url=https://www.liebertpub.com/doi/abs/10.1089/scd.2020.0146 |journal=Stem Cells and Development |volume=29 |issue=22 |pages=1417–1419 |doi=10.1089/scd.2020.0146 |pmid=32967574 |s2cid=221888407 |issn=1547-3287}}</ref> and has been considered to be possibly "impossible".<ref name=":14" /> However, scientists have successfully created eggs from male mice to produce offspring with 2 biologically male genetic donors and have been optimistic that human application could come within the next 10 years.<ref>{{Cite news |last1=Devlin |first1=Hannah |last2=correspondent |first2=Hannah Devlin Science |date=2023-03-08 |title=Scientists create mice with two fathers after making eggs from male cells |language=en-GB |work=The Guardian |url=https://www.theguardian.com/science/2023/mar/08/scientists-create-mice-with-two-fathers-after-making-eggs-from-male-cells |access-date=2023-11-30 |issn=0261-3077}}</ref><ref>{{Cite web |last=Hunt |first=Katie |date=2023-03-24 |title=Scientists create mice from two dads after making eggs from skin cells |url=https://www.cnn.com/2023/03/24/world/mice-eggs-from-male-cells-scn/index.html |access-date=2023-11-30 |website=CNN |language=en}}</ref>
{{See also|Reproduction and pregnancy in speculative fiction}}


For prepubertal transgender girls, testicular tissue cryopreservation (TTC) is currently the only fertility preservation option.<ref name=":8" /> An experimental surgical procedure to remove and cryopreserve testicular tissue for a later date when the spermatogonial stem cells can be matured into sperm. To date no spermatogenic recovery has been reported and TTC technologies enabling this are currently only being studied in animal models<ref name=":8" />
Male pregnancy is commonly explored in [[Slash fiction|slash]] (homosexual) [[fan fiction]], usually based upon fantasy series such as ''[[Supernatural (U.S. TV series)|Supernatural]]'' or ''[[Harry Potter (series)|Harry Potter]]''.<ref name="Astrom2010">{{cite journal | vauthors = Astrom B |title="Let's get those Winchesters pregnant": Male pregnancy in "Supernatural" fan fiction |year=2010 |journal=Transformative Works and Cultures |volume=4 |issue=4 |doi=10.3983/twc.2010.0135 |doi-access=free |title-link=Transformative Works and Cultures}}</ref><ref name="Ingram-Waters2008">{{cite book | vauthors = Ingram-Waters MC |url=https://books.google.com/books?id=sKBa9PzhwisC&pg=PA27 |title=Unnatural Babies: Cultural Conceptions of Deviant Procreations |year=2008 | publisher=University of California, Santa Barbara |isbn=9780549700333}}</ref>

There is theoretical work being done on creating a [[zygote]] from two women which would enable both women to be biological mothers, but it is yet to be practically implemented.<ref name = "Ringler_2015" /> Creating a sperm from an egg and using it to fertilize another egg may offer a solution to this issue,<ref name="Murray_2021" /> as could a process analogous to [[somatic cell nuclear transfer]] involving two eggs being fused together.<ref>{{Cite web | vauthors = Foster H |date=2013-08-16|title=Mommy 1 and Mommy 2: Could science end the age of Mom and Dad?|url=https://sitn.hms.harvard.edu/flash/2013/mommy-1-and-mommy-2-could-science-end-the-age-of-mom-and-dad/|access-date=2021-07-05|website=Science in the News|language=en-US}}</ref>

In 2004 and 2018 scientists were able to create mice with two mothers via egg fusion.<ref name="the-washington-post-2004a" /><ref name="blakely-2018a" /><ref name="li-2018a" /> Modification of [[genomic imprinting]] was necessary to create healthy bimaternal mice, while live bipaternal mice were created but were unhealthy likely due to genomic imprinting.<ref name="li-2018a" />

If created, a "female sperm" cell could fertilize an egg cell, a procedure that, among other potential applications, might enable female [[same-sex couple]]s to produce a child who would be the biological offspring of their two mothers. It is also claimed that production of female sperm may stimulate a woman to be both the mother and father (similar to asexual reproduction) of an offspring produced by her own sperm. Many queries, both ethical and moral, arise over these arguments.<ref>{{cite web|url=http://www.ncl.ac.uk/press.office/press.release/item/1176449611|title=Early-stage sperm cells created|publisher=[[Newcastle University]]|date=2007-04-13|url-status=dead|archive-url=https://web.archive.org/web/20131109045059/http://www.ncl.ac.uk/press.office/press.release/item/1176449611|archive-date=2013-11-09}}</ref><ref>{{cite news|url=https://www.telegraph.co.uk/news/uknews/1548492/Women-may-be-able-to-grow-own-sperm.html|title=Women may be able to grow own sperm|date=2007-04-14|publisher=Daily Telegraph | location=London | vauthors = Highfield R | access-date=2010-05-02}}</ref><ref>{{cite news|url=http://pierretristam.com/Bobst/07/wf041307a.htm|title=The prospect of all-female conception|work=[[The Independent]]|date=2007-04-13|location=London| vauthors = Connor S |access-date=2010-05-02|archive-url=https://web.archive.org/web/20110106164544/http://pierretristam.com/Bobst/07/wf041307a.htm|archive-date=2011-01-06|url-status=dead}}</ref><ref>{{cite news|url=https://www.newscientist.com/article/dn11601-bone-stem-cells-turned-into-primitive-sperm-cells.html|title=Bone stem cells turned into primitive sperm cells|publisher=[[New Scientist]]|date=2007-04-13}}</ref>

=== Uterine transplantation ===

Some trans women want to carry their own children through [[transgender pregnancy]], which has its own set of issues to be overcome, because transgender women do not naturally have the anatomy needed for embryonic and fetal development. As of 2008, there were no successful cases of [[uterus transplant]]ation concerning a transgender woman.<ref>{{cite news| vauthors = Leith W |date=2008-04-10|title=Pregnant men: hard to stomach?|newspaper=Telegraph|location=London|url=https://www.telegraph.co.uk/men/active/mens-health/3354220/Pregnant-men-hard-to-stomach.html}}</ref>

Another possibility for transgender women would come from a successful [[Uterus transplantation|uterus transplant]] that can carry a pregnancy to term in a transgender women.<ref name=":12">{{Cite journal |last1=Jones |first1=BP |last2=Williams |first2=NJ |last3=Saso |first3=S |last4=Thum |first4=M-Y |last5=Quiroga |first5=I |last6=Yazbek |first6=J |last7=Wilkinson |first7=S |last8=Ghaem-Maghami |first8=S |last9=Thomas |first9=P |last10=Smith |first10=JR |date=January 2019 |title=Uterine transplantation in transgender women |journal=BJOG |volume=126 |issue=2 |pages=152–156 |doi=10.1111/1471-0528.15438 |issn=1470-0328 |pmc=6492192 |pmid=30125449}}</ref> There have been successful births with uterus transplantation in cis-women, but currently non in trans women<ref name=":12" /> as currently there have been no successful uterus transplants in transgender women.<ref name=":13">{{Cite journal |last1=Richards |first1=Elliott G. |last2=Ferrando |first2=Cecile A. |last3=Farrell |first3=Ruth M. |last4=Flyckt |first4=Rebecca L. |date=March 2023 |title=A "first" on the horizon: the expansion of uterus transplantation to transgender women |url=http://dx.doi.org/10.1016/j.fertnstert.2023.01.017 |journal=Fertility and Sterility |volume=119 |issue=3 |pages=390–391 |doi=10.1016/j.fertnstert.2023.01.017 |pmid=36669554 |s2cid=256057677 |issn=0015-0282}}</ref> Theoretical problems arise in the [[sexual dimorphism]] of the human pelvis, drug regime risk (post-transplant immunosuppression and hormone therapy to sustain implantation and pregnancy), and risk of neovaginal anastomosis.<ref name=":12" /><ref name=":13" /><ref name=":17">{{Cite journal |last1=Mookerjee |first1=Vikram G. |last2=Kwan |first2=Daniel |date=2019-04-25 |title=Uterus transplantation as a fertility option in transgender healthcare |journal=International Journal of Transgender Health |volume=21 |issue=2 |pages=122–124 |doi=10.1080/15532739.2019.1599764 |issn=2689-5269 |pmc=7430417 |pmid=33005906}}</ref> The same studies that identified these risks also came to the conclusion that despite the considerations uterine transplant shouldn't be confined to cis-women,<ref name=":12" /><ref name=":13" /><ref name=":17" /> with one journal article unable to find any increase in theoretical procedural risk compared to cis-women.<ref name=":17" /> There is no expectation that trans women would give birth through the neo-vaginal canal.<ref>{{Cite journal |last1=Balayla |first1=Jacques |last2=Pounds |first2=Pauline |last3=Lasry |first3=Ariane |last4=Volodarsky-Perel |first4=Alexander |last5=Gil |first5=Yaron |date=May 2021 |title=The Montreal Criteria and uterine transplants in transgender women |url=https://onlinelibrary.wiley.com/doi/10.1111/bioe.12832 |journal=Bioethics |language=en |volume=35 |issue=4 |pages=326–330 |doi=10.1111/bioe.12832 |pmid=33550647 |s2cid=231862917 |issn=0269-9702}}</ref>

As of 2019, in cisgender women, more than 42 UTx procedures had been performed, with 12 live births resulting from the transplanted uteruses as of publication.<ref>{{cite journal | vauthors = Jones BP, Williams NJ, Saso S, Thum MY, Quiroga I, Yazbek J, Wilkinson S, Ghaem-Maghami S, Thomas P, Smith JR | display-authors = 6 | title = Uterine transplantation in transgender women | journal = BJOG | volume = 126 | issue = 2 | pages = 152–156 | date = January 2019 | pmid = 30125449 | pmc = 6492192 | doi = 10.1111/1471-0528.15438 }}</ref> The International Society of Uterine Transplantation (ISUTx) was established internationally in 2016, with 70 clinical doctors and scientists, and currently has 140 intercontinental delegates.<ref>{{Cite web|title=History of ISUTx|url=https://www.isutx.org/about/|work=International Society for Uterus Transplantation (ISUTx)|access-date=2021-07-26|archive-date=2021-11-23|archive-url=https://web.archive.org/web/20211123223505/https://www.isutx.org/about/|url-status=dead}}</ref> Its goal is to, "through scientific innovations, advance medical care in the field of uterus transplantation."<ref>{{Cite web|title=About - 'Vision'|url=https://www.isutx.org/about/#vision-row|work=International Society for Uterus Transplantation (ISUTx)|access-date=2021-07-26|archive-date=2021-11-23|archive-url=https://web.archive.org/web/20211123223505/https://www.isutx.org/about/#vision-row|url-status=dead}}</ref>

In 2012, [[McGill University]] published the "Montreal Criteria for the Ethical Feasibility of Uterine Transplantation", a proposed set of criteria for carrying out uterine transplants, in ''Transplant International''.<ref name="Montreal">{{cite journal | vauthors = Lefkowitz A, Edwards M, Balayla J | title = The Montreal Criteria for the Ethical Feasibility of Uterine Transplantation | journal = Transplant International | volume = 25 | issue = 4 | pages = 439–47 | date = April 2012 | pmid = 22356169 | doi = 10.1111/j.1432-2277.2012.01438.x | s2cid = 39516819 | doi-access = free }}</ref> Under these criteria, only a [[cisgender]] woman could ethically be considered a transplant recipient. The exclusion of trans women from candidacy may lack justification.<ref>{{cite journal | vauthors = Lefkowitz A, Edwards M, Balayla J | title = Ethical considerations in the era of the uterine transplant: an update of the Montreal Criteria for the Ethical Feasibility of Uterine Transplantation | journal = Fertility and Sterility | volume = 100 | issue = 4 | pages = 924–6 | date = October 2013 | pmid = 23768985 | doi = 10.1016/j.fertnstert.2013.05.026 | quote = However, it certainly bears mentioning that there does not seem to be a prima facie ethical reason to reject the idea of performing uterine transplant on a male or trans patient. A male or trans patient wishing to gestate a child does not have a lesser claim to that desire than their female counterparts. The principle of autonomy is not sex-specific. This right is not absolute, but it is not the business of medicine to decide what is unreasonable to request for a person of sound mind, except as it relates to medical and surgical risk, as well as to distribution of resources. A male who identifies as a woman, for example, arguably has UFI, no functionally different from a woman who is born female with UFI. Irrespective of the surgical challenges involved, such a person's right to self-governance of her reproductive potential ought to be equal to her genetically female peers and should be respected. | doi-access = free }}</ref>

In addition, if trans women wish to conceive with a biological male partner, they face the same issues that cisgender gay couples have in creating a zygote.

== In popular culture ==


In the [[Omegaverse]] themes of LGBT reproduction are common.<ref name="sung-2021a">{{Cite web | vauthors = Sung M |date=26 April 2021 |title=What The Hell Is The Omegaverse, And Why Is It All Over TikTok? |url=https://in.mashable.com/culture/21810/what-the-hell-is-the-omegaverse-and-why-is-it-all-over-tiktok |access-date=5 April 2022 |website=Mashable India |language=en-in}}</ref><ref name="Jezebel">{{cite news | vauthors = Shrayber M |date=18 June 2014 |title='Knotting' Is the Weird Fanfic Sex Trend That Cannot Be Unseen |language=en-us |work=[[Jezebel (website)|Jezebel]] |url=https://jezebel.com/knotting-is-the-weird-fanfic-sex-trend-that-cannot-be-u-1606931767 |access-date=25 May 2020}}</ref><ref name="男も妊娠する世界-2018a">{{Cite web |date=10 July 2018 |title=男も妊娠する世界…BLの人気設定「オメガバース」ってご存知ですか |url=http://gendai.ismedia.jp/articles/-/56273 |access-date=5 April 2022 |language=ja}}</ref><ref name="animate-times-2022a">{{Cite web |title=2ページ目:BLにおける「オメガバースの事情」【アニメイト編集部BL塾・応用編】 {{!}} アニメイトタイムズ |url=https://www.animatetimes.com/news/details.php?id=1607068841&p=2 |access-date=7 April 2022 |website=Animate Times |language=ja}}</ref> Alpha females are able to impregnate both males and females,<ref name="sung-2021a" /> and Omega males are able to be impregnated by both males and females.<ref name="Jezebel" /><ref name="男も妊娠する世界-2018a" /><ref name="animate-times-2022a" />
In the [[Omegaverse]] themes of LGBT reproduction are common.<ref name="sung-2021a">{{Cite web | vauthors = Sung M |date=26 April 2021 |title=What The Hell Is The Omegaverse, And Why Is It All Over TikTok? |url=https://in.mashable.com/culture/21810/what-the-hell-is-the-omegaverse-and-why-is-it-all-over-tiktok |access-date=5 April 2022 |website=Mashable India |language=en-in}}</ref><ref name="Jezebel">{{cite news | vauthors = Shrayber M |date=18 June 2014 |title='Knotting' Is the Weird Fanfic Sex Trend That Cannot Be Unseen |language=en-us |work=[[Jezebel (website)|Jezebel]] |url=https://jezebel.com/knotting-is-the-weird-fanfic-sex-trend-that-cannot-be-u-1606931767 |access-date=25 May 2020}}</ref><ref name="男も妊娠する世界-2018a">{{Cite web |date=10 July 2018 |title=男も妊娠する世界…BLの人気設定「オメガバース」ってご存知ですか |url=http://gendai.ismedia.jp/articles/-/56273 |access-date=5 April 2022 |language=ja}}</ref><ref name="animate-times-2022a">{{Cite web |title=2ページ目:BLにおける「オメガバースの事情」【アニメイト編集部BL塾・応用編】 {{!}} アニメイトタイムズ |url=https://www.animatetimes.com/news/details.php?id=1607068841&p=2 |access-date=7 April 2022 |website=Animate Times |language=ja}}</ref> Alpha females are able to impregnate both males and females,<ref name="sung-2021a" /> and Omega males are able to be impregnated by both males and females.<ref name="Jezebel" /><ref name="男も妊娠する世界-2018a" /><ref name="animate-times-2022a" />

Revision as of 06:32, 30 December 2023

Diagram of the proposed method of lesbian egg fusion

LGBT reproduction refers to lesbian, gay, bisexual, and transgender (LGBT) people having biological children by means of assisted reproductive technology. It is distinct from LGBT parenting, which is a broader cultural phenomenon including LGBT adoption. In recent decades, developmental biologists have been researching and developing techniques to facilitate same-sex reproduction.[1][2]

The obvious approaches, subject to a growing amount of activity, are female sperm and male eggs. In 2004, by altering the function of a few genes involved with imprinting, other Japanese scientists combined two mouse eggs to produce daughter mice[3] and in 2018 Chinese scientists created 29 female mice from two female mice mothers but were unable to produce viable offspring from two father mice.[4][5] One of the possibilities is obtaining sperm and eggs from skin stem cells.[6]

Lack of access to assisted reproductive technologies has been seen as a form of healthcare inequality experienced by LGBT people.[7]

Artificial insemination

Donating sperm

Trans women may have lower sperm quality before HRT, which may pose an issue for creating viable sperm samples to freeze.[8]

Estrogens suppress testosterone levels and at high doses can markedly disrupt sex drive and function and fertility on their own.[9][10][11][12] Moreover, disruption of gonadal function and fertility by estrogens may be permanent after extended exposure.[11][12][13]

Nonsteroidal antiandrogens like bicalutamide may be an option for transgender women who wish to preserve sex drive, sexual function, and/or fertility, relative to antiandrogens that suppress testosterone levels and can greatly disrupt these functions such as cyproterone acetate and GnRH modulators.[14][15][16] However, estrogens suppress testosterone levels and at high doses can markedly disrupt sex drive and function and fertility on their own.[17][18][19][20] Moreover, disruption of gonadal function and fertility by estrogens may be permanent after extended exposure.[19][20]

Picking sperm

Prospective parents must carefully consider where they get their donor sperm from. Indvidual state's laws vary, but many U.S states have adopted a form of the Uniform Parentage Act (UPA).[21] Most, but not all states transfer parental rights from anonymous sperm donors to the intended parents as long as the recipient is a married woman, and a physician is involved.[21] Noncompliance with these laws can result in the failure to terminate sperm donor parental rights. There have been court cases where known sperm donors that privately donated directly were requested to pay child support.[21][22][23][24] For example, of these laws, see California assisted reproductive laws. In Australia, there has been legal precedent that sperm donor involvement with the ensuing child's life does grant them parental rights (Masson v Parsons).[25]

Alternative to direct private donation it is possible to purchase sperm from a sperm bank for personal use in fertility treatment. Sperm banks can vary widely, not only in terms of price, but of practice (i.e who is allowed to donate sperm, how many times, etc) and can offer a variety of services. Major U.S sperm banks include Fairfax Cryobank, California Cyrobank, Cryos International, Seattle Sperm bank, and Xytex, and many others.

Procedures

Timing of these procedures are critical for successful fertilization,[26] as the fertile window is the five days before ovulation, plus the day of and after ovulation.[27] To increase the chance of success, the menstrual cycle is closely observed, often using ovulation kits, ultrasounds or blood tests, such as basal body temperature tests over, noting the color and texture of the vaginal mucus, and the softness of the nose of the cervix.[27] To improve the success rate of artificial insemination, drugs to create a stimulated cycle may be used called ovarian stimulation (OS).

Before ovulation there is a surge of luteinizing hormone (LH) which can be used to time an IUI procedure. Data suggest that IUI should be performed 1 day after the detection of the LH surge.[26] Most clinics in the U.S perform IUI in the morning after a positive ovulation predictor kit test (which detects LH in urine).[26] An alternative to LH monitoring is ultrasound monitoring of ovarian follicle size followed by a trigger shot with exogenous human chorionic gonadotropin (hCG) which mimics the body’s LH surge and triggers final follicular maturation and rupture (36–48 hours later). The trigger shot is typically administered when the dominant follicle reaches 18–20 mm.[26] The recommended timing of IUI after hCG administration is 24–40 hours.[26] IUI cycles stimulated with classical doses of FSH have a high rate of have a multiple pregnancy with rates ranging from 10 to 40%.[28] A meta-analysis showed no difference between pregnancy outcomes between at-home LH monitoring and timed IUI.[26]

IUI can be done without the use of medication. IUI is not recommended in cases where the gestating individuals have cervical atresia, cervicitis, endometritis or bilateral tubal obstruction or when the sperm donor has amenorrhea or severe oligospermia.[28] Prior to IUI, the sperm is "washed" which is necessary to remove seminal plasma to avoid prostaglandin-induced uterine contractions.[28] Insemination with unprocessed semen is also associated with pelvic infection.[28]

Diagram of the IUI procedure

Intrauterine insemination (IUI) involves the opening of the vagina using a speculum, then injecting washed sperm directly into the uterus with a catheter.[29] Insemination in this way means that the sperm do not have to swim through the cervix which is coated with a mucus layer. This layer of mucus can slow down the passage of sperm and can result in many sperm perishing before they can enter the uterus.[30] Donor sperm is sometimes tested for mucus penetration capabilities if it is to be used for ICI inseminations, for if the sperm's chances of passing through the cervix is low, IUI would provide a more efficient delivery of the sperm than ICI [citation needed]. IUI fertilization takes place naturally in the external part of the fallopian tubes in the same way that occurs following intercourse.

The benefit of double IUI has not been found in patients with undocumented infertility using donor sperm, such as lesbian and single women.[31] Typically pregnancy success rates per IUI cycle is approximately 12.4%.[32] According to a study from 2021, lesbian women undergoing IUI had a clinical pregnancy rate of 13.2% per cycle and 42.2% success rate given the average number of cycles at 3.6.[32] IUI has been reported to be more effective than ICI[33][34] but this has been contested with some citing no strong evidence to confirm a significant difference between the birth rates of the two procedures.[35] It is speculated that IUI is more effective since IUI brings the sperm closer to the oocyte than ICI which might compensate for decreased sperm motility after freezing and thawing.[34] IUI includes risk of endometritis, cramping, bleeding, and anaphylaxis (rarely).[33] A systematic review and meta-analysis was not able to demonstrate that bed rest after intrauterine insemination effectively increases in pregnancy rate.[36]

Very similar to IUI, Intracervical insemination (ICI) is the method of artificial insemination which most closely mimics the natural ejaculation of semen by the penis into the vagina during sexual intercourse. ICI is the simplest method of artificial insemination and may also be performed privately in the home instead of at a private practice. ICI is the process of introducing semen into the vagina at the entrance to the cervix,[37] usually by means of a needleless syringe. Sperm used in ICI inseminations does not have to be 'washed' to remove seminal fluid so raw semen from a private donor may be used. Semen supplied by a sperm bank prepared for ICI or IUI use is also suitable for ICI. A retrospective cohort study showed that total motility and total motile count (TMC) after thawing were associated with ongoing pregnancy rate; with best ICI results at total motility of ≥20% and a total motile count (TMC) of ≥8 × 106 after thawing.[38]

During ICI, air is expelled from a needleless syringe which is then filled with semen. A specially-designed syringe, wider and with a more rounded end, may be used for this purpose. Any further enclosed air is removed by gently pressing the plunger forward. The recipient lies on their back and the syringe is inserted into the vagina so that the tip is as close to the entrance to the cervix as possible. A vaginal speculum may be used for this purpose and a catheter may be attached to the tip of the syringe to ensure delivery of the semen as close to the entrance to the cervix as possible. The plunger is then slowly pushed forward and the semen in the syringe is gently emptied deep into the vagina. It is important that the syringe is emptied slowly for safety and for the best results, bearing in mind that the purpose of the procedure is the replicate as closely as possible a natural deposit of the semen in the vagina[citation needed]. The syringe (and catheter if used) may be left in place for several minutes before removal. Following insemination, fertile sperm will swim through the cervix into the uterus and from there to the fallopian tubes in a natural way as if the sperm had been deposited in the vagina through intercourse. A conception cap instead of a syringe can be used as well.

Intracytoplasmic sperm injection
IVF drugs

In vitro fertilization

Standard IVF

Standard IVF is the process by which the egg is removed from the ovaries and fertilized outside of the body, and then the pre-embryo is implanted into a uterus[39].  There are many steps to ensure that this process works including ovary stimulation, egg collection, fertilization, and embryo transfer.  To stimulate the ovaries to produce more eggs than usual, the person must take specific hormones prescribed by a doctor[39].  Then, the eggs are collected using an ultrasound-guided aspiration needle.  Once the eggs are outside the body, they are mixed with sperm in a culture dish in the hopes of fertilization.  The sperm used can come from any sperm donor (either from a sperm bank, or a known donor like a partner).  If a pre-embryo forms, it remains in the incubator for two to five days while it continues to grow and divide.  At this stage, the pre-embryo is often genetically tested to ensure that it will develop into a healthy baby.  If the embryo is deemed healthy, the next step is implantation[39].  The embryos are transferred to the uterus which involves an ultrasound being used to guide a catheter through the cervix and into the uterine cavity.[39]

Reciprocal IVF

Partner-assisted reproduction, or co-IVF is a method of family building that is used by couples who both possess female reproductive organs. The method uses in vitro fertilization (IVF), a method that means eggs are removed from the ovaries, fertilized in a laboratory, and then one or more of the resulting embryos are placed in the uterus to hopefully create a pregnancy. Reciprocal IVF differs from standard IVF in that two women are involved: the eggs are taken from one partner, and the other partner carries the pregnancy.[40] In this way, the process is mechanically identical to IVF with egg donation.[41][42] Using this process ensures that each partner is a biological mother of the child according to advocates,[43] but in the strictest sense only one mother is the biological mother from a genetic standpoint and the other is a surrogate mother. However the practice has a symbolic weight greater than LGBT adoption, and may create a stronger bond between mother and child than adoption.

In a 2019 study, quality of infant–parent relationships was examined among egg donor families in comparison to in vitro fertilization families.[44] Infants were between the ages of 6–18 months. Through use of the Parent Development Interview (PDI) and observational assessment, the study found few differences between family types on the representational level, yet significant differences between family types on the observational level.[44] Egg donation mothers were less sensitive and structuring than IVF mothers, and egg donation infants were less emotionally responsive, and involving than IVF infants.[44] [45] The eggs are then fertilized with donor sperm to create embryos, one of which can then be transferred to the second person’s uterus. In this way, one partner contributes the genetic material and the second partner contributes the maternal environment, allowing both partners to have a profound impact on the development of the fetus and child[45].  The laws around parenthood when both partners do not contribute genetic material are complicated and vary by state, so it is imperative to do research before beginning the process.[45]

Freezing eggs

Many gay transgender men choose to freeze their eggs before transitioning, and choose to have a female surrogate carry their child while when the time comes, using their eggs and their cis male partner's sperm. This allows them to avoid the potentially dysphoria inducing experience of pregnancy, or cessation of HRT for collecting eggs at an older age.[46][47]

Natural pregnancy

Surrogacy

Some gay or transsexual couples decide to have a surrogate pregnancy. A surrogate is a woman carrying an egg fertilized by sperm of one of the men. Some women become surrogates for money, others for humanitarian reasons or both.[48] This allows one of the men to be the biological father while the other will be an adopted father.

Gay men who have become fathers using surrogacy have reported similar experiences to those as other couples who have used surrogacy, including their relationships both their child and their surrogate have.[49]

There is theoretical work being done on creating a zygote from two men which would enable both men to be biological fathers, but it is yet to be practically implemented.[50]

Barrie and Tony Drewitt-Barlow from the United Kingdom became the first gay men in the country to father twins born through surrogacy in 1999.[51][52]

Surrogate parents attending birth

Surrogacy is a process in which a woman carries and delivers a child for a couple or an individual. This can be an arrangement supported by a legal agreement where the surrogate may or may not be compensated. Surrogacy is the most common form of accessing parenthood because it is less complicated due to the biological connection made between parent and child. LGBTQ+ individuals may seek surrogacy when they are in need for someone else to serve as the gestational carrier of their biological child. Recently, traveling for couples outside of the US to seek surrogacy is rising. Usually these commercial services cater only white, wealthy parents-to-be. In some countries it is illegal to pay surrogates, but the debate is that unpaid surrogacy can take place.

Choosing who will be the biological parent can vary from couple to couple because couples get to decide where gametes can come from. Gametes can be purchased through commercial resources, arranged through an agreement from a genetic connection to both parents, or through a friend donation.

There is a long history of transnational surrogacy used by gay parents who seek surrogacy in India. They use gametes fertilized by one or both parents to inseminate local women who are employed through an agency. There is global criticism due to transparency around pay and the outcomes for the parties involved. Because of this surrogacy services in India are being recalled by gay parents because there is restricted access to pregnancy updates. Unable to communicate can create emotional distancing for gay parents and the pregnancy can be stressful for gay parents. Going through surrogate services can be a stressful journey because gay parents are caught up in between charts and graphs, instead of being able to have an emotional connection with the baby through the surrogate and the experiences they go through.

Transnational surrogacy can raise legal issues when the child is born. There is conflict about national legal rules on parentage and this complicates citizenship, which can often result in the child not having legal parents or citizenship in any country.

The World Profession Association for Transgender Health (WPATH) recommends that all transgender patients make decisions regarding their fertility before starting hormone therapy in their Standards of Care (2012) guidebook for medical professionals.[53]

Transgender men

Pregnancy is possible for transgender men who retain a functioning vagina, ovaries, and a uterus.[54][55] Exposure to hormonal testosterone treatment does not necessarily preclude the possibility live birth.[56] Testosterone therapy by itself is not a sufficient method of contraception, and trans men may experience unintended pregnancy[57][58] especially if they miss doses.[57] Many trans men who have become pregnant were able to do so within six months of stopping testosterone.[57]  Another study conducted in 2019 found that transgender male patients seeking oocyte retrieval for either oocyte cryopreservation, embryo cryopreservation, or IVF were able to undergo treatment 4 months after stopping testosterone treatment, on average.[59] There have been no studies of transgender men attempting pregnancy after testosterone or on the health of offspring conceived from testosterone-exposed oocytes, so exact fertility rates are unknown.[60][54]

Masculinizing hormonal therapy in trans men will lead to irreversible amenorrhea, however androgen therapy does not deplete primordial follicles nor affects the developmental capacity of the follicles, but histologically hyperplasia of ovarian cortex and stroma has been found.[61] It has been debated if this is physiologically comparable to polycystic ovary syndrome.[61] Ovariectomies lead to irreversible fertility termination (if the eggs are not stored), but doesn't preclude gestational pregnancy with ART.[61][54] Hysterectomies will eliminate the option to gestate.[54]

For preservation of reproductive possibilities:

  1. Oocyte banking: Cryopreservation of oocytes requires hormonal stimulation and oocyte retrieval, as for IVF treatment, after which the oocytes are vitrified.[61] Vitrification of oocytes has been found to be more successful than slow freezing oocytes.[62] The success of oocyte banking declines significantly with increasing reproductive age[53] Ovarian stimulation will increase transgender men's serum estradiol levels, and in response transvaginal ultrasound monitoring may be necessary, strategies to minimize estradiol elevations include the concomitant use of aromatase inhibitors during stimulation.[60] There is no data on the success of ovarian stimulation in transgender men who previously had puberty halted with GnRH agonist, followed directly by testosterone administration.[60] There is also no data comparing the number of oocytes retrieved or the live-birth rate after fertility preservation stratified by time off testosterone.[56]
    • Results with oocytes vitrification (viability, fertilization and pregnancy) have been improving.
  2. Embryo banking: Freezing of embryos is a possibility; but requires the use of available sperm for embryo creation. Preservation of embryos is common high efficiency procedure performed at fertility centers.[61]
  3. Banking of ovarian tissue: A surgical procedure is required to collect tissue samples, if undergoing a hysterectomy and/or ovariectomy, one can choose to cryopreserve some tissue at the same time to avoid an additional surgical procedure.[61] Ovarian tissue cryopreservation has been successful, but so far, there have been no pregnancies recorded after thawing and in-vitro maturation (IVM) of this tissue, successful pregnancies have only been recorded after auto-transplantation.[63][61] This method has a very low success rate of blastocyst development as in one study of 83 transgender males, 2 out of the 208 mature oocytes were recovered from thawed ovarian tissue created "good-quality" blastocysts.[56]

Transgender women

Some transgender women have reported a lower sexual desire on hormonal treatment.[64] It has been found that transgender patients undergoing feminizing hormonal therapy do have abnormal semen parameters.[65][66] Sustained hormonal treatment eventually leads to hypo-spermatogenesis and ultimately azoospermia which will become irreversible at an unknown point in time.[61][67][68] A 2015 study did demonstrate normal spermatogenesis in long term estrogen therapy patients.[53] Surgical removal of testicles also leads to irreversible sterility.[61][68] It is recommended for those pursing these options and interested in preserving fertility to cryogenically store their sperm before starting their treatment.[61]

Semen can be collected via masturbation, but there are alternatives for those who find masturbation or ejaculation distressing or may have erectile or ejaculatory dysfunction secondary to hypoandrogenism. Options for those with dysfunction include: penile vibratory stimulation and electroejaculation.[60] For those who do not want to ejaculate or have oligospermia or azoospermia can pursue testicular sperm aspiration or microsurgical sperm extraction although they are more invasive.[60] There are currently no studies evaluating the acceptability or success rates of the different options for sperm collection specifically in transgender women.[60] Furthermore, for transgender women on estradiol and/or antiandrogens, it is unclear the length of time needed to be off hormonal treatment medication before normal spermatogenesis resumes (if it occurs at all), during which time testosterone production will resume and may cause unwanted masculinizing effects.[60]

Body-feeding

The term body-feeding refers to the feeding of one's baby milk to an infant directly from one's body.[69] Body-feeding is essential for the development of infants.[70] Though there is a large transgender and gender diverse population, the quantitative and qualitative research regarding body-feeding is relatively small.[71] Though widely known as breastfeeding, new gender-affirming terms have developed: body-feeding and chest-feeding. These terms took note after transgender males (female to male) found discomfort in the terms "breastfeeding" and "lactation".

Studies done on the breastfeeding or chestfeeding practices of transgender or gender diverse parents are extremely limited. A study done focused on the socio-demographic characteristics among parents with different breastfeeding or chestfeeding practices shows that mixed/artificial feeding (the use of formula and breast (or chest) milk) is widely used for families with higher annual incomes (100-200k) with 73.0% utilizing mixed/artificial feeding.[72] Results from this study show that most transgender or gender diverse populations prefer mixed/artificial feedings instead of exclusive chestfeeding.[73]

Lactation as a transwoman

Lactation in trans women is an understudied area.[74] A survey of trans healthcare providers found 34% met trans women who expressed interest in inducing lactation.[75] The first documented instance of a trans woman attempting to breastfeed was in 2018 using domperidone to induce lactation.[76] In 2021, lactation was successfully induced in a trans woman.[77]

To induce lactation, domperidone is used at a dosage of 10 to 20 mg 3 or 4 times per day by mouth.[78] Effects may be seen within 24 hours or after 3 or 4 days.[78] The maximum effect occurs after 2 or 3 weeks of treatment, and the treatment period generally lasts for 3 to 8 weeks.[78]

Barriers to fertility care

Economic

Fertility treatment and preservation is expensive. The average IVF cycle can cost $12,000 to $17,000 (not including medication), with medication it can up to $25,000-$30,000 [79][80] and price often comes down to one's insurance which might come with come with stipulations. The cost of IUI ranges from $500-4,000 per cycle.[81] Cryopreservation of genetic material is also costly see table below and can vary greatly from place to place, state to state.[82]

Fertility preservation Option Service Cost Range ($) Annual Storage Cost Range ($)
Egg Freezing 7,000-15,000 300-1000[82][83]
Embryo freezing 11,000-15,000 350-600[80]
Ovarian Tissue Freezing 10,000-12,000 300-500
Sperm Banking 250-1,000[84] 100-500[85]
Testicular Sperm Extraction 7,500-10,000 300-500
Electroejaculation 10,000-12,000 300-500

Another barrier is knowledge. These procedures are not well known and discussion of fertility preservation are uncommon. In a study of 133 transgender women 61% stated that no health care provider discussed sperm banking prior to their hormone therapy or surgery.[86] In another study, 70 transgender males cited barriers such as the perceived cost of treatment (36%), need for discontinuation or delay of hormonal therapy (19%), and worsening gender dysphoria with treatment and pregnancy (11%).[56]

Physical

Only 3% of transgender people take efforts to preserve their fertility in transition[87] 51% of trans women express regrets for not preserving their fertility,[88] and 97% of transgender adults believe it should be discussed before transition.[89]

Testosterone therapy affects fertility, but many trans men who have become pregnant were able to do so within six months of stopping testosterone. [90] Another study conducted in 2019 found that transgender male patients seeking oocyte retrieval for either oocyte cryopreservation, embryo cryopreservation, or IVF were able to undergo treatment 4 months after stopping testosterone treatment, on average.[91] All patients experienced menses and normal AMH, FSH, and E2 levels and antral follicle counts after coming off testosterone which allowed for successful oocyte retrieval.[91] Although the long-term effects of androgen treatment on fertility is still widely unknown, oocyte retrieval does not appear to be affected. Future pregnancies can be achieved by oophyte banking, but the process may increase gender dysphoria or may not be accessible due to lack of insurance coverage.[90] Testosterone therapy is not a sufficient method of contraception, and trans men may experience unintended pregnancy,[90][92] especially if they miss doses.[90]

Some studies report a higher incidence of polycystic ovary syndrome (PCOS) among transgender men prior to taking testosterone,[93][94][95] the disease causes infertility and can make it harder for trans men to freeze eggs,[96] though not all have not found the same association of trans men and PCOS.[97] People with PCOS in general are also reportedly more likely to see themselves as "sexually undifferentiated" or "androgynous" and "less likely to identify with a female gender scheme."[98][97]

Future technology

There is theoretical potential for same sex reproduction using stem cells to derive gametes to produce biologically related children,[99] but this has been contentious[100] and has been considered to be possibly "impossible".[99] However, scientists have successfully created eggs from male mice to produce offspring with 2 biologically male genetic donors and have been optimistic that human application could come within the next 10 years.[101][102]

For prepubertal transgender girls, testicular tissue cryopreservation (TTC) is currently the only fertility preservation option.[60] An experimental surgical procedure to remove and cryopreserve testicular tissue for a later date when the spermatogonial stem cells can be matured into sperm. To date no spermatogenic recovery has been reported and TTC technologies enabling this are currently only being studied in animal models[60]

There is theoretical work being done on creating a zygote from two women which would enable both women to be biological mothers, but it is yet to be practically implemented.[50] Creating a sperm from an egg and using it to fertilize another egg may offer a solution to this issue,[6] as could a process analogous to somatic cell nuclear transfer involving two eggs being fused together.[103]

In 2004 and 2018 scientists were able to create mice with two mothers via egg fusion.[3][4][5] Modification of genomic imprinting was necessary to create healthy bimaternal mice, while live bipaternal mice were created but were unhealthy likely due to genomic imprinting.[5]

If created, a "female sperm" cell could fertilize an egg cell, a procedure that, among other potential applications, might enable female same-sex couples to produce a child who would be the biological offspring of their two mothers. It is also claimed that production of female sperm may stimulate a woman to be both the mother and father (similar to asexual reproduction) of an offspring produced by her own sperm. Many queries, both ethical and moral, arise over these arguments.[104][105][106][107]

Uterine transplantation

Some trans women want to carry their own children through transgender pregnancy, which has its own set of issues to be overcome, because transgender women do not naturally have the anatomy needed for embryonic and fetal development. As of 2008, there were no successful cases of uterus transplantation concerning a transgender woman.[108]

Another possibility for transgender women would come from a successful uterus transplant that can carry a pregnancy to term in a transgender women.[109] There have been successful births with uterus transplantation in cis-women, but currently non in trans women[109] as currently there have been no successful uterus transplants in transgender women.[110] Theoretical problems arise in the sexual dimorphism of the human pelvis, drug regime risk (post-transplant immunosuppression and hormone therapy to sustain implantation and pregnancy), and risk of neovaginal anastomosis.[109][110][111] The same studies that identified these risks also came to the conclusion that despite the considerations uterine transplant shouldn't be confined to cis-women,[109][110][111] with one journal article unable to find any increase in theoretical procedural risk compared to cis-women.[111] There is no expectation that trans women would give birth through the neo-vaginal canal.[112]

As of 2019, in cisgender women, more than 42 UTx procedures had been performed, with 12 live births resulting from the transplanted uteruses as of publication.[113] The International Society of Uterine Transplantation (ISUTx) was established internationally in 2016, with 70 clinical doctors and scientists, and currently has 140 intercontinental delegates.[114] Its goal is to, "through scientific innovations, advance medical care in the field of uterus transplantation."[115]

In 2012, McGill University published the "Montreal Criteria for the Ethical Feasibility of Uterine Transplantation", a proposed set of criteria for carrying out uterine transplants, in Transplant International.[116] Under these criteria, only a cisgender woman could ethically be considered a transplant recipient. The exclusion of trans women from candidacy may lack justification.[117]

In addition, if trans women wish to conceive with a biological male partner, they face the same issues that cisgender gay couples have in creating a zygote.

In the Omegaverse themes of LGBT reproduction are common.[118][119][120][121] Alpha females are able to impregnate both males and females,[118] and Omega males are able to be impregnated by both males and females.[119][120][121]

Between Alphas and Betas, only females can carry on a pregnancy, but male Omegas are often envisaged as being able to become pregnant via an uterus connected to the rectum,[119][120][121] and Alphas can impregnate regardless of their main gender.[118] To make penetration and impregnation easier, male Omegas often have self-lubricating anuses.[122]

See also

References

  1. ^ Quick D (9 December 2010). "Breakthrough raises possibility of genetic children for same-sex couples". Retrieved 26 July 2015.
  2. ^ "Timeline of same-sex procreation scientific developments". samesexprocreation.com.
  3. ^ a b "Japanese scientists produce mice without using sperm". The Washington Post. Sarasota Herald-Tribune. April 22, 2004.
  4. ^ a b Blakely R (2018-10-12). "No father necessary as mice are created with two mothers". The Times. ISSN 0140-0460. Retrieved 2018-10-12.
  5. ^ a b c Li ZK, Wang LY, Wang LB, Feng GH, Yuan XW, Liu C, et al. (November 2018). "Generation of Bimaternal and Bipaternal Mice from Hypomethylated Haploid ESCs with Imprinting Region Deletions". Cell Stem Cell. 23 (5): 665–676.e4. doi:10.1016/j.stem.2018.09.004. PMID 30318303.
  6. ^ a b Murray I (2021). "Stem Cells and Same Sex Reproduction". Retrieved 26 July 2015.
  7. ^ Tam MW (August 2021). "Queering reproductive access: reproductive justice in assisted reproductive technologies". Reproductive Health. 18 (1): 164. doi:10.1186/s12978-021-01214-8. PMC 8327458. PMID 34340704.
  8. ^ Li K, Rodriguez D, Gabrielsen JS, Centola GM, Tanrikut C (November 2018). "Sperm cryopreservation of transgender individuals: trends and findings in the past decade". Andrology. 6 (6): 860–864. doi:10.1111/andr.12527. PMC 6301129. PMID 30094956.
  9. ^ Jones CA, Reiter L, Greenblatt E (2016). "Fertility preservation in transgender patients". International Journal of Transgenderism. 17 (2): 76–82. doi:10.1080/15532739.2016.1153992. ISSN 1553-2739. S2CID 58849546. Traditionally, patients have been advised to cryopreserve sperm prior to starting cross-sex hormone therapy as there is a potential for a decline in sperm motility with high-dose estrogen therapy over time (Lubbert et al., 1992). However, this decline in fertility due to estrogen therapy is controversial due to limited studies.
  10. ^ Payne AH, Hardy MP (28 October 2007). The Leydig Cell in Health and Disease. Springer Science & Business Media. pp. 422–431. ISBN 978-1-59745-453-7. Estrogens are highly efficient inhibitors of the hypothalamic-hypophyseal-testicular axis (212–214). Aside from their negative feedback action at the level of the hypothalamus and pituitary, direct inhibitory effects on the testis are likely (215,216). [...] The histology of the testes [with estrogen treatment] showed disorganization of the seminiferous tubules, vacuolization and absence of lumen, and compartmentalization of spermatogenesis.
  11. ^ a b Salam MA (2003). Principles & Practice of Urology: A Comprehensive Text. Universal-Publishers. pp. 684–. ISBN 978-1-58112-412-5. Estrogens act primarily through negative feedback at the hypothalamic-pituitary level to reduce LH secretion and testicular androgen synthesis. [...] Interestingly, if the treatment with estrogens is discontinued after 3 yr. of uninterrupted exposure, serum testosterone may remain at castration levels for up to another 3 yr. This prolonged suppression is thought to result from a direct effect of estrogens on the Leydig cells.
  12. ^ a b Cox RL, Crawford ED (December 1995). "Estrogens in the treatment of prostate cancer". The Journal of Urology. 154 (6): 1991–8. doi:10.1016/S0022-5347(01)66670-9. PMID 7500443.
  13. ^ Adeleye AJ, Reid G, Kao CN, Mok-Lin E, Smith JF (February 2019). "Semen Parameters Among Transgender Women With a History of Hormonal Treatment". Urology. 124: 136–141. doi:10.1016/j.urology.2018.10.005. PMID 30312673. S2CID 52973277.
  14. ^ Gao Y, Maurer T, Mirmirani P (August 2018). "Understanding and Addressing Hair Disorders in Transgender Individuals". American Journal of Clinical Dermatology. 19 (4): 517–527. doi:10.1007/s40257-018-0343-z. PMID 29352423. S2CID 6467968. Non-steroidal antiandrogens include flutamide, nilutamide, and bicalutamide, which do not lower androgen levels and may be favorable for individuals who want to preserve sex drive and fertility [9].
  15. ^ Iversen P, Melezinek I, Schmidt A (January 2001). "Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function". BJU International. 87 (1): 47–56. doi:10.1046/j.1464-410x.2001.00988.x. PMID 11121992. S2CID 28215804.
  16. ^ Morgante E, Gradini R, Realacci M, Sale P, D'Eramo G, Perrone GA, et al. (March 2001). "Effects of long-term treatment with the anti-androgen bicalutamide on human testis: an ultrastructural and morphometric study". Histopathology. 38 (3): 195–201. doi:10.1046/j.1365-2559.2001.01077.x. hdl:11573/387981. PMID 11260298. S2CID 36892099.
  17. ^ Jones CA, Reiter L, Greenblatt E (2016). "Fertility preservation in transgender patients". International Journal of Transgenderism. 17 (2): 76–82. doi:10.1080/15532739.2016.1153992. ISSN 1553-2739. S2CID 58849546. Traditionally, patients have been advised to cryopreserve sperm prior to starting cross-sex hormone therapy as there is a potential for a decline in sperm motility with high-dose estrogen therapy over time (Lubbert et al., 1992). However, this decline in fertility due to estrogen therapy is controversial due to limited studies.
  18. ^ Payne AH, Hardy MP (28 October 2007). The Leydig Cell in Health and Disease. Springer Science & Business Media. pp. 422–431. ISBN 978-1-59745-453-7. Estrogens are highly efficient inhibitors of the hypothalamic-hypophyseal-testicular axis (212–214). Aside from their negative feedback action at the level of the hypothalamus and pituitary, direct inhibitory effects on the testis are likely (215,216). [...] The histology of the testes [with estrogen treatment] showed disorganization of the seminiferous tubules, vacuolization and absence of lumen, and compartmentalization of spermatogenesis.
  19. ^ a b Salam MA (2003). Principles & Practice of Urology: A Comprehensive Text. Universal-Publishers. pp. 684–. ISBN 978-1-58112-412-5. Estrogens act primarily through negative feedback at the hypothalamic-pituitary level to reduce LH secretion and testicular androgen synthesis. [...] Interestingly, if the treatment with estrogens is discontinued after 3 yr. of uninterrupted exposure, serum testosterone may remain at castration levels for up to another 3 yr. This prolonged suppression is thought to result from a direct effect of estrogens on the Leydig cells.
  20. ^ a b Cox RL, Crawford ED (December 1995). "Estrogens in the treatment of prostate cancer". The Journal of Urology. 154 (6): 1991–1998. doi:10.1016/S0022-5347(01)66670-9. PMID 7500443.
  21. ^ a b c Luetkemeyer, Lisa; West, Kimela (2015). "Paternity Law: Sperm Donors, Surrogate Mothers and Child Custody". Missouri Medicine. 112 (3): 162–165. ISSN 0026-6620. PMC 6170122. PMID 26168582.
  22. ^ Narayan, Chandrika (2014-01-23). "Kansas court says sperm donor must pay child support". CNN. Retrieved 2023-11-16.
  23. ^ "Court voids ruling that sperm donor must pay child support". AP News. 2021-06-16. Retrieved 2023-11-16.
  24. ^ "Do Sperm Donors Pay Child Support?". Boyd Law. 2018-07-16. Retrieved 2023-11-16.
  25. ^ Seery, Cassandra (2019-06-19). "Can a sperm donor be a legal parent? In landmark decision, the High Court says yes". The Conversation. Retrieved 2023-11-16.
  26. ^ a b c d e f Potapragada, Nivedita R.; Babayev, Elnur; Strom, Danielle; Beestrum, Molly; Schauer, Jacob M.; Jungheim, Emily S. (2023-06-07). "Intrauterine Insemination After Human Chorionic Gonadotropin Trigger or Luteinizing Hormone Surge". Obstetrics & Gynecology. 142 (1): 61–70. doi:10.1097/aog.0000000000005222. ISSN 0029-7844. S2CID 259118454.
  27. ^ a b "Calculating Your Monthly Fertility Window". www.hopkinsmedicine.org. 2022-03-10. Retrieved 2023-12-04.
  28. ^ a b c d The ESHRE Capri Workshop Group (2009-01-16). "Intrauterine insemination". Human Reproduction Update. 15 (3): 265–277. doi:10.1093/humupd/dmp003. ISSN 1355-4786. PMID 19240042.
  29. ^ "Intrauterine insemination (IUI) - Mayo Clinic". www.mayoclinic.org. Retrieved 2023-11-26.
  30. ^ "IUI (Intrauterine Insemination): What It Is & What To Expect". Cleveland Clinic. Retrieved 2023-11-26.
  31. ^ Monseur, Brent C.; Franasiak, Jason M.; Sun, Li; Scott, Richard T.; Kaser, Daniel J. (2019-10-01). "Double intrauterine insemination (IUI) of no benefit over single IUI among lesbian and single women seeking to conceive". Journal of Assisted Reproduction and Genetics. 36 (10): 2095–2101. doi:10.1007/s10815-019-01561-3. ISSN 1573-7330. PMC 6823402. PMID 31410635.
  32. ^ a b Johal, Jasmyn K.; Gardner, Rebecca M.; Vaughn, Sara J.; Jaswa, Eleni G.; Hedlin, Haley; Aghajanova, Lusine (2021-04-28). "Pregnancy success rates for lesbian women undergoing intrauterine insemination". F&S Reports. 2 (3): 275–281. doi:10.1016/j.xfre.2021.04.007. ISSN 2666-3341. PMC 8441558. PMID 34553151.
  33. ^ a b Chen, Xiao-Jun; Wu, Li-Ping; Lan, Hai-Lian; Zhang, Li; Zhu, Yi-Min (2012). "Clinical Variables Affecting The Pregnancy Rate of Intracervical Insemination Using Cryopreserved Donor Spermatozoa: A Retrospective Study in China". International Journal of Fertility & Sterility. 6 (3): 179–184. ISSN 2008-076X. PMC 3850307. PMID 24520436.
  34. ^ a b Kop, P A L; van Wely, M; Nap, A; Soufan, A T; de Melker, A A; Mol, B W J; Bernardus, R E; De Brucker, M; Janssens, P M W; Pieters, J J P M; Repping, S; van der Veen, F; Mochtar, M H (2022-04-23). "Intracervical insemination versus intrauterine insemination with cryopreserved donor sperm in the natural cycle: a randomized controlled trial". Human Reproduction. 37 (6): 1175–1182. doi:10.1093/humrep/deac071. ISSN 0268-1161. PMC 9789751. PMID 35459949.
  35. ^ Kop, Petronella AL; Mochtar, Monique H; O'Brien, Paul A; Van der Veen, Fulco; van Wely, Madelon (2018-01-25). "Intrauterine insemination versus intracervical insemination in donor sperm treatment". Cochrane Database of Systematic Reviews. 2018 (2): CD000317. doi:10.1002/14651858.cd000317.pub4. ISSN 1465-1858. PMC 6491301. PMID 29368795.
  36. ^ Cordary, D.; Braconier, A.; Guillet-May, F.; Morel, O.; Agopiantz, M.; Callec, R. (2017-12-01). "Immobilization versus immediate mobilization after intrauterine insemination: A systematic review and meta-analysis". Journal of Gynecology Obstetrics and Human Reproduction. 46 (10): 747–751. doi:10.1016/j.jogoh.2017.09.005. ISSN 2468-7847. PMID 28964965.
  37. ^ "Intracervical insemination (ICI) -". 2022-10-08. Retrieved 2023-11-28.
  38. ^ Kop, Petronella; van Wely, Madelon; de Melker, Annemieke; van der Veen, Fulco; Mochtar, Monique (2022-02-04). "Donor sperm treatment: the role of semen parameters in intracervical insemination, a retrospective cohort study". Human Fertility. 26 (5): 964–970. doi:10.1080/14647273.2022.2032407. ISSN 1464-7273. PMID 35114884. S2CID 246529633.
  39. ^ a b c d MarketingInsights. "Standard IVF". The IVF Center | Assisted Reproduction and Endocrinology. Retrieved 2023-12-04.
  40. ^ Gilmour P (6 June 2018). "Shared motherhood: The amazing way lesbian couples are having babies". Cosmopolitan. Retrieved 21 March 2018.
  41. ^ Klatsky P (22 June 2017). "Co-Maternity And Reciprocal IVF: Empowering lesbian parents with options". Huffington Post. Retrieved 21 March 2018.
  42. ^ Marina S, Marina D, Marina F, Fosas N, Galiana N, Jové I (April 2010). "Sharing motherhood: biological lesbian co-mothers, a new IVF indication". Human Reproduction. 25 (4): 938–41. doi:10.1093/humrep/deq008. PMID 20145005.
  43. ^ Schenker JG (2011). Ethical dilemmas in assisted reproductive technologies. Berlin: De Gruyter. ISBN 978-3-11-024021-4. OCLC 763156926.
  44. ^ a b c Imrie S, Jadva V, Fishel S, Golombok S (July 2019). "Families Created by Egg Donation: Parent-Child Relationship Quality in Infancy". Child Development. 90 (4): 1333–1349. doi:10.1111/cdev.13124. PMC 6640047. PMID 30015989.
  45. ^ a b c "Reciprocal IVF | UCSF Center for Reproductive Health". UCSF. Retrieved 2023-12-04.
  46. ^ Compton J (5 March 2019). "Transgender men, eager to have biological kids, are freezing their eggs". NBC News. Retrieved 2021-07-05.
  47. ^ "The T-Male: IVF and Surrogacy". www.thetransitionalmale.com. Retrieved 2021-07-05.
  48. ^ "For Gay Men: Becoming a Parent through Surrogacy". Internet Health Resources. Retrieved 26 July 2015.
  49. ^ Blake L, Carone N, Slutsky J, Raffanello E, Ehrhardt AA, Golombok S (November 2016). "Gay father surrogacy families: relationships with surrogates and egg donors and parental disclosure of children's origins". Fertility and Sterility. 106 (6): 1503–1509. doi:10.1016/j.fertnstert.2016.08.013. PMC 5090043. PMID 27565261.
  50. ^ a b Ringler G (18 March 2015). "Get Ready for Embryos From Two Men or Two Women". Retrieved 4 July 2021.
  51. ^ Woodward W (13 December 1999). "Gay couple celebrate birth of twins Aspen and Saffron". The Guardian.
  52. ^ Wakefield L (13 December 2021). "Britain's 'first gay dads' expecting triplets with daughter's ex-boyfriend". PinkNews.
  53. ^ a b c Jones, C. A.; Reiter, L.; Greenblatt, E. (2016-04-02). "Fertility preservation in transgender patients". International Journal of Transgenderism. 17 (2): 76–82. doi:10.1080/15532739.2016.1153992. ISSN 1553-2739. S2CID 58849546.
  54. ^ a b c d Obedin-Maliver, Juno; Makadon, Harvey J (March 2016). "Transgender men and pregnancy". Obstetric Medicine. 9 (1): 4–8. doi:10.1177/1753495X15612658. ISSN 1753-495X. PMC 4790470. PMID 27030799.
  55. ^ Leung, Angela; Sakkas, Denny; Pang, Samuel; Thornton, Kim; Resetkova, Nina (2019-11-01). "Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine". Fertility and Sterility. 112 (5): 858–865. doi:10.1016/j.fertnstert.2019.07.014. ISSN 0015-0282. PMID 31594633.
  56. ^ a b c d Douglas, Christopher R.; Phillips, Destiny; Sokalska, Anna; Aghajanova, Lusine (2022-05-02). "Fertility Preservation for Transgender Males". Obstetrics & Gynecology. 139 (6): 1012–1017. doi:10.1097/aog.0000000000004751. ISSN 0029-7844. PMID 35675598. S2CID 249332982.
  57. ^ a b c Berger, Anthony P.; Potter, Elizabeth M.; Shutters, Christina M.; Imborek, Katherine L. (2015-09-01). "Pregnant transmen and barriers to high quality healthcare". Proceedings in Obstetrics and Gynecology. 5 (2): 1–12. doi:10.17077/2154-4751.1285. ISSN 2154-4751.
  58. ^ Light, Alexis; Wang, Lin-Fan; Zeymo, Alexander; Gomez-Lobo, Veronica (2018-10-01). "Family planning and contraception use in transgender men". Contraception. 98 (4): 266–269. doi:10.1016/j.contraception.2018.06.006. ISSN 0010-7824. PMID 29944875. S2CID 49434157.
  59. ^ Leung, Angela; Sakkas, Denny; Pang, Samuel; Thornton, Kim; Resetkova, Nina (2019-11-01). "Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine". Fertility and Sterility. 112 (5): 858–865. doi:10.1016/j.fertnstert.2019.07.014. ISSN 0015-0282. PMID 31594633.
  60. ^ a b c d e f g h i Moravek, Molly B. (June 2019). "Fertility preservation options for transgender and gender-nonconforming individuals". Current Opinion in Obstetrics and Gynecology. 31 (3): 170–176. doi:10.1097/GCO.0000000000000537. ISSN 1040-872X. PMID 30870185. S2CID 78091839.
  61. ^ a b c d e f g h i j T'Sjoen, Guy; Van Caenegem, Eva; Wierckx, Katrien (December 2013). "Transgenderism and reproduction". Current Opinion in Endocrinology, Diabetes & Obesity. 20 (6): 575–579. doi:10.1097/01.med.0000436184.42554.b7. ISSN 1752-296X. PMID 24468761. S2CID 205398449.
  62. ^ Herrero, Leyre; Martínez, Mónica; Garcia-Velasco, Juan A. (August 2011). "Current status of human oocyte and embryo cryopreservation". Current Opinion in Obstetrics and Gynecology. 23 (4): 245–250. doi:10.1097/GCO.0b013e32834874e2. ISSN 1040-872X. PMID 21734500. S2CID 32837692.
  63. ^ Donnez, J; Dolmans, MM; Demylle, D; Jadoul, P; Pirard, C; Squifflet, J; Martinez-Madrid, B; Van Langendonckt, A (October 2004). "Livebirth after orthotopic transplantation of cryopreserved ovarian tissue". The Lancet. 364 (9443): 1405–1410. doi:10.1016/s0140-6736(04)17222-x. ISSN 0140-6736. PMID 15488215. S2CID 21448970.
  64. ^ Wierckx, Katrien; Van Caenegem, Eva; Schreiner, Thomas; Haraldsen, Ira; Fisher, Alessandra; Toye, Kaatje; Kaufman, Jean Marc; T'Sjoen, Guy (August 2014). "Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short-Time Follow-Up: Results from the European Network for the Investigation of Gender Incongruence". The Journal of Sexual Medicine. 11 (8): 1999–2011. doi:10.1111/jsm.12571. hdl:2158/1060207. ISSN 1743-6095. PMID 24828032.
  65. ^ Li, Kai; Rodriguez, Dayron; Gabrielsen, J. Scott; Centola, Grace M.; Tanrikut, Cigdem (November 2018). "Sperm Cryopreservation of Transgender Individuals: Trends and Findings in the Past Decade". Andrology. 6 (6): 860–864. doi:10.1111/andr.12527. ISSN 2047-2919. PMC 6301129. PMID 30094956.
  66. ^ Adeleye, Amanda J.; Reid, Garrett; Kao, Chia-Ning; Mok-Lin, Evelyn; Smith, James F. (2019-02-01). "Semen Parameters Among Transgender Women With a History of Hormonal Treatment". Urology. 124: 136–141. doi:10.1016/j.urology.2018.10.005. ISSN 0090-4295. PMID 30312673. S2CID 52973277.
  67. ^ Rowlands, Sam; Amy, Jean-Jacques (2018-01-02). "Preserving the reproductive potential of transgender and intersex people". The European Journal of Contraception & Reproductive Health Care. 23 (1): 58–63. doi:10.1080/13625187.2017.1422240. ISSN 1362-5187. PMID 29323576. S2CID 3784307.
  68. ^ a b Amir, Hadar; Yaish, Iris; Oren, Asaf; Groutz, Asnat; Greenman, Yona; Azem, Foad (2020-09-01). "Fertility preservation rates among transgender women compared with transgender men receiving comprehensive fertility counselling". Reproductive BioMedicine Online. 41 (3): 546–554. doi:10.1016/j.rbmo.2020.05.003. ISSN 1472-6483. PMID 32651108. S2CID 219435735.
  69. ^ "It's time to add "chestfeeding" to your vocabulary". Today's Parent. 2021-06-09. Retrieved 2023-12-04.
  70. ^ [sciencedirect.com/science/article/pii/S258953702300024X "Rates of breastfeeding or chestfeeding and influencing factors among transgender and gender-diverse parents: a cross sectional study"]. {{cite web}}: Check |url= value (help)
  71. ^ Yang, Haibing; Na, Xiaona; Zhang, Yanwen; Xi, Menglu; Yang, Yucheng; Chen, Runsen; Zhao, Ai (2023). "Rates of breastfeeding or chestfeeding and influencing factors among transgender and gender-diverse parents: a cross sectional study". eClinicalMedicine. 57. doi:10.1016/j.eclinm.2023.101847. PMC 9971548. PMID 36864982.
  72. ^ Yang, Haibing; Na, Xiaona; Zhang, Yanwen; Xi, Menglu; Yang, Yucheng; Chen, Runsen; Zhao, Ai (2023). "Rates of breastfeeding or chestfeeding and influencing factors among transgender and gender-diverse parents: a cross sectional study". eClinicalMedicine. 57. doi:10.1016/j.eclinm.2023.101847. PMC 9971548. PMID 36864982.
  73. ^ Yang, Haibing; Na, Xiaona; Zhang, Yanwen; Xi, Menglu; Yang, Yucheng; Chen, Runsen; Zhao, Ai (2023). "Rates of breastfeeding or chestfeeding and influencing factors among transgender and gender-diverse parents: a cross sectional study". eClinicalMedicine. 57. doi:10.1016/j.eclinm.2023.101847. PMC 9971548. PMID 36864982.
  74. ^ García-Acosta JM, San Juan-Valdivia RM, Fernández-Martínez AD, Lorenzo-Rocha ND, Castro-Peraza ME (December 2019). "Trans* Pregnancy and Lactation: A Literature Review from a Nursing Perspective". International Journal of Environmental Research and Public Health. 17 (1): E44. doi:10.3390/ijerph17010044. PMC 6981677. PMID 31861638.
  75. ^ Trautner E, McCool-Myers M, Joyner AB (July 2020). "Knowledge and practice of induction of lactation in trans women among professionals working in trans health". International Breastfeeding Journal. 15 (1): 63. doi:10.1186/s13006-020-00308-6. PMC 7364529. PMID 32678042.
  76. ^ Glenza J (February 14, 2018). "Transgender woman able to breastfeed in first documented case". The Guardian. London. Archived from the original on 2018-02-14.
  77. ^ Wamboldt R, Shuster S, Sidhu BS (April 2021). "Lactation Induction in a Transgender Woman Wanting to Breastfeed: Case Report". The Journal of Clinical Endocrinology and Metabolism. 106 (5): e2047–e2052. doi:10.1210/clinem/dgaa976. PMID 33513241. S2CID 231755160.
  78. ^ a b c Henderson A (2003). "Domperidone. Discovering new choices for lactating mothers". AWHONN Lifelines. 7 (1): 54–60. doi:10.1177/1091592303251726. PMID 12674062.
  79. ^ Klein, Amy (2020-04-18). "I.V.F. is Expensive. Here's How to Bring Down the Cost". The New York Times. ISSN 0362-4331. Retrieved 2023-12-04.
  80. ^ a b "How Much Does IVF Cost?". Forbes Health. 2021-09-28. Retrieved 2023-12-04.
  81. ^ Snider, Susannah (September 29, 2020). ""How Much Does IUI Cost and How Do I Pay for It?"". U.S. News.
  82. ^ a b "Paying For Treatments". Alliance for Fertility Preservation. Retrieved 2023-12-04.
  83. ^ PFCLA. "Cost of Egg & Embryo Freezing in the U.S. | PFCLA". www.pfcla.com. Retrieved 2023-12-04.
  84. ^ "How Much Does It Cost To Freeze Sperm?". Forbes Health. 2022-12-01. Retrieved 2023-12-04.
  85. ^ "Sperm Banking". www.hopkinsmedicine.org. 2021-11-02. Retrieved 2023-12-04.
  86. ^ Asafu-Adjei*, Denise; Caputo, Joseph M.; Bockting, Walter O.; Diah, Jonathan; Alukal, Joseph; Stahl, Peter J. (April 2020). "MP26-16 Mismatch Between Attitudes Towards Fertility and Clinical Care for Fertility Preservation in Transgender Women: Data From Project Affirm". Journal of Urology. 203 (Supplement 4). doi:10.1097/ju.0000000000000865.016. ISSN 0022-5347.
  87. ^ Nahata L, Tishelman AC, Caltabellotta NM, Quinn GP (July 2017). "Low Fertility Preservation Utilization Among Transgender Youth". The Journal of Adolescent Health. 61 (1): 40–44. doi:10.1016/j.jadohealth.2016.12.012. PMID 28161526.
  88. ^ "IJ TRANSGENDER - The Desire to have Children and the Preservation of Fertility in Transsexual Women: A Survey". 2021-06-30. Archived from the original on 2021-06-30. Retrieved 2022-02-23.
  89. ^ "Many transgender individuals consider their fertility important, survey shows". www.endocrine.org. Retrieved 2022-02-23.
  90. ^ a b c d Berger AP, Potter EM, Shutters CM, Imborek KL (2015). "Pregnant transmen and barriers to high quality healthcare". Proceedings in Obstetrics and Gynecology. 5 (2): 1–12. doi:10.17077/2154-4751.1285.
  91. ^ a b Cite error: The named reference leung-2019a was invoked but never defined (see the help page).
  92. ^ Light A, Wang LF, Zeymo A, Gomez-Lobo V (October 2018). "Family planning and contraception use in transgender men". Contraception. 98 (4): 266–269. doi:10.1016/j.contraception.2018.06.006. PMID 29944875. S2CID 49434157.
  93. ^ Baba T, Endo T, Honnma H, Kitajima Y, Hayashi T, Ikeda H, et al. (April 2007). "Association between polycystic ovary syndrome and female-to-male transsexuality". Human Reproduction. 22 (4): 1011–1016. CiteSeerX 10.1.1.519.7356. doi:10.1093/humrep/del474. PMID 17166864.
  94. ^ Becerra-Fernández A, Pérez-López G, Román MM, Martín-Lazaro JF, Lucio Pérez MJ, Asenjo Araque N, et al. (August 2014). "Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals" [Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals]. Endocrinologia y Nutricion (in Spanish). 61 (7): 351–358. doi:10.1016/j.endonu.2014.01.010. PMID 24680383. S2CID 162299777.
  95. ^ Balen AH, Schachter ME, Montgomery D, Reid RW, Jacobs HS (March 1993). "Polycystic ovaries are a common finding in untreated female to male transsexuals". Clinical Endocrinology. 38 (3): 325–329. doi:10.1111/j.1365-2265.1993.tb01013.x. PMID 8458105. S2CID 72741370.
  96. ^ "What are the symptoms of PCOS?". Eunice Kennedy Shriver National Institute of Child Health and Human Development.
  97. ^ a b Cesta CE, Månsson M, Palm C, Lichtenstein P, Iliadou AN, Landén M (November 2016). "Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort". Psychoneuroendocrinology. 73: 196–203. doi:10.1016/j.psyneuen.2016.08.005. hdl:10616/45608. PMID 27513883. S2CID 207460386.
  98. ^ Kowalczyk R, Skrzypulec V, Lew-Starowicz Z, Nowosielski K, Grabski B, Merk W (June 2012). "Psychological gender of patients with polycystic ovary syndrome". Acta Obstetricia et Gynecologica Scandinavica. 91 (6): 710–714. doi:10.1111/j.1600-0412.2012.01408.x. PMID 22443151. S2CID 25055401.
  99. ^ a b Segers, Seppe; Mertes, Heidi; Pennings, Guido; de Wert, Guido; Dondorp, Wybo (2017-01-25). "Using stem cell-derived gametes for same-sex reproduction: an alternative scenario". Journal of Medical Ethics. 43 (10): 688–691. doi:10.1136/medethics-2016-103863. ISSN 0306-6800. PMID 28122990. S2CID 35387886.
  100. ^ Adashi, Eli Y.; Cohen, I. Glenn (2020-11-15). "Assisted Same-Sex Reproduction: The Promise of Haploid Stem Cells?". Stem Cells and Development. 29 (22): 1417–1419. doi:10.1089/scd.2020.0146. ISSN 1547-3287. PMID 32967574. S2CID 221888407.
  101. ^ Devlin, Hannah; correspondent, Hannah Devlin Science (2023-03-08). "Scientists create mice with two fathers after making eggs from male cells". The Guardian. ISSN 0261-3077. Retrieved 2023-11-30. {{cite news}}: |last2= has generic name (help)
  102. ^ Hunt, Katie (2023-03-24). "Scientists create mice from two dads after making eggs from skin cells". CNN. Retrieved 2023-11-30.
  103. ^ Foster H (2013-08-16). "Mommy 1 and Mommy 2: Could science end the age of Mom and Dad?". Science in the News. Retrieved 2021-07-05.
  104. ^ "Early-stage sperm cells created". Newcastle University. 2007-04-13. Archived from the original on 2013-11-09.
  105. ^ Highfield R (2007-04-14). "Women may be able to grow own sperm". London: Daily Telegraph. Retrieved 2010-05-02.
  106. ^ Connor S (2007-04-13). "The prospect of all-female conception". The Independent. London. Archived from the original on 2011-01-06. Retrieved 2010-05-02.
  107. ^ "Bone stem cells turned into primitive sperm cells". New Scientist. 2007-04-13.
  108. ^ Leith W (2008-04-10). "Pregnant men: hard to stomach?". Telegraph. London.
  109. ^ a b c d Jones, BP; Williams, NJ; Saso, S; Thum, M-Y; Quiroga, I; Yazbek, J; Wilkinson, S; Ghaem-Maghami, S; Thomas, P; Smith, JR (January 2019). "Uterine transplantation in transgender women". BJOG. 126 (2): 152–156. doi:10.1111/1471-0528.15438. ISSN 1470-0328. PMC 6492192. PMID 30125449.
  110. ^ a b c Richards, Elliott G.; Ferrando, Cecile A.; Farrell, Ruth M.; Flyckt, Rebecca L. (March 2023). "A "first" on the horizon: the expansion of uterus transplantation to transgender women". Fertility and Sterility. 119 (3): 390–391. doi:10.1016/j.fertnstert.2023.01.017. ISSN 0015-0282. PMID 36669554. S2CID 256057677.
  111. ^ a b c Mookerjee, Vikram G.; Kwan, Daniel (2019-04-25). "Uterus transplantation as a fertility option in transgender healthcare". International Journal of Transgender Health. 21 (2): 122–124. doi:10.1080/15532739.2019.1599764. ISSN 2689-5269. PMC 7430417. PMID 33005906.
  112. ^ Balayla, Jacques; Pounds, Pauline; Lasry, Ariane; Volodarsky-Perel, Alexander; Gil, Yaron (May 2021). "The Montreal Criteria and uterine transplants in transgender women". Bioethics. 35 (4): 326–330. doi:10.1111/bioe.12832. ISSN 0269-9702. PMID 33550647. S2CID 231862917.
  113. ^ Jones BP, Williams NJ, Saso S, Thum MY, Quiroga I, Yazbek J, et al. (January 2019). "Uterine transplantation in transgender women". BJOG. 126 (2): 152–156. doi:10.1111/1471-0528.15438. PMC 6492192. PMID 30125449.
  114. ^ "History of ISUTx". International Society for Uterus Transplantation (ISUTx). Archived from the original on 2021-11-23. Retrieved 2021-07-26.
  115. ^ "About - 'Vision'". International Society for Uterus Transplantation (ISUTx). Archived from the original on 2021-11-23. Retrieved 2021-07-26.
  116. ^ Lefkowitz A, Edwards M, Balayla J (April 2012). "The Montreal Criteria for the Ethical Feasibility of Uterine Transplantation". Transplant International. 25 (4): 439–47. doi:10.1111/j.1432-2277.2012.01438.x. PMID 22356169. S2CID 39516819.
  117. ^ Lefkowitz A, Edwards M, Balayla J (October 2013). "Ethical considerations in the era of the uterine transplant: an update of the Montreal Criteria for the Ethical Feasibility of Uterine Transplantation". Fertility and Sterility. 100 (4): 924–6. doi:10.1016/j.fertnstert.2013.05.026. PMID 23768985. However, it certainly bears mentioning that there does not seem to be a prima facie ethical reason to reject the idea of performing uterine transplant on a male or trans patient. A male or trans patient wishing to gestate a child does not have a lesser claim to that desire than their female counterparts. The principle of autonomy is not sex-specific. This right is not absolute, but it is not the business of medicine to decide what is unreasonable to request for a person of sound mind, except as it relates to medical and surgical risk, as well as to distribution of resources. A male who identifies as a woman, for example, arguably has UFI, no functionally different from a woman who is born female with UFI. Irrespective of the surgical challenges involved, such a person's right to self-governance of her reproductive potential ought to be equal to her genetically female peers and should be respected.
  118. ^ a b c Sung M (26 April 2021). "What The Hell Is The Omegaverse, And Why Is It All Over TikTok?". Mashable India. Retrieved 5 April 2022.
  119. ^ a b c Shrayber M (18 June 2014). "'Knotting' Is the Weird Fanfic Sex Trend That Cannot Be Unseen". Jezebel. Retrieved 25 May 2020.
  120. ^ a b c "男も妊娠する世界…BLの人気設定「オメガバース」ってご存知ですか" (in Japanese). 10 July 2018. Retrieved 5 April 2022.
  121. ^ a b c "2ページ目:BLにおける「オメガバースの事情」【アニメイト編集部BL塾・応用編】 | アニメイトタイムズ". Animate Times (in Japanese). Retrieved 7 April 2022.
  122. ^ Fazekas A (2020). "Alpha/Beta/Omega: Racialized Narratives and Fandom's Investment in Whiteness". In Pande R (ed.). Fandom, Now in Color: A Collection of Voices. University of Iowa Press. p. 98. ISBN 9781609387297 – via Project MUSE.